HYATON ORGANICS INC
10KSB40, 2000-04-14
AGRICULTURAL CHEMICALS
Previous: PARK HILL CAPITAL I CORP, 10QSB, 2000-04-14
Next: VARIABLE LIFE ACCOUNT C OF AETNA LIFE INSURANCE & ANNUITY CO, 485BPOS, 2000-04-14






                       SECURITIES AND EXCHANGE COMMISSION
                              Washington DC. 20549

                                   FORM 10-KSB

[X]     ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
        ACT OF 1934  For the fiscal year ended December 31, 1999

[ ]     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
        ACT OF 1934 For the transition period from __________ to ___________.

Commission file number:  0-27853

                              HYATON ORGANICS INC.
             (Exact name of registrant as specified in its charter)

           Nevada                                         86-0913555
(State or other jurisdiction of              (IRS Employer Identification No.)
  incorporation or organization)


                     1500 West Georgia Street, 13th Floor,
                  Vancouver, British Columbia, Canada V6G 2Z6
              (Address of principal executive offices) (Zip Code)

                                 (604) 623-3300
              (Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or such shorter period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
at least the past 90 days.  Yes     X    No

Indicate by check mark if disclosure of delinquent  filers  pursuant to Item 405
of Regulation  S-K is not contained  herein,  and will not be contained,  to the
best of registrant's  knowledge,  in definitive proxy or information  statements
incorporated  by reference  in Part III of this Form 10-KSB or any  amendment to
this Form 10-KSB. X

As of March 15, 2000,  the  aggregate  market value for the shares of the common
stock, no par value, held by non-affiliates was approximately $71,782,020.

The number of shares  outstanding of registrant's only class of common stock, as
of March 15, 2000, was 27,556,000 shares of its common stock, no par value.

Documents Incorporated by Reference: None

Exhibit Index is located at Page 18.

<PAGE>2


With the exception of historical facts stated herein,  the following  discussion
may contain  forward- looking  statements  regarding events and financial trends
which may affect the Company's future operating results and financial  position.
Such  statements  are  subject to risks and  uncertainties  that could cause the
Company's actual results and financial  position to differ materially from those
anticipated in such forward-looking statements.  Factors that could cause actual
results to differ materially include, in addition to other factors identified in
this report, the Company's  operating losses,  its need for additional  capital,
its ability to commercially develop its proposed products, and dependence on key
personnel,  all of which  factors are set forth in more  detail in the  sections
entitled "Certain  Considerations" and "Management's  Discussion and Analysis or
Plan of Operation" herein. Readers of this report are cautioned not to put undue
reliance on "forward looking"  statements which are, by their nature,  uncertain
as reliable indicators of future  performance.  The Company disclaims any intent
or obligation to publicly update these "forward looking" statements,  whether as
a result of new information, future events, or otherwise.

        In this  statement,  all dollar  amounts are  expressed in United States
dollars unless otherwise stated.

                                     PART I.

Item 1.  Description of Business

                              BUSINESS DEVELOPMENT

Historical Information

        Hyaton  Organics Inc.  ("Hyaton" or the "Company") was  incorporated  in
Nevada on August 20, 1996,  under the name  Hayoton  Company  Incorporated  as a
management company for resorts and hotel properties.  In September 24, 1996, the
Company  changed its name from Hayoton  Company  Incorporated  to Hyaton Company
Incorporated  and then to Hyaton  Organics Inc. on October 21, 1999. The Company
was dormant until June 1997,  when the Board  reevaluated  its business plan and
decided to focus the Company's business on commodity  production and/or purchase
and  resale of same  through  strategic  alliances  with  leading  environmental
corporations.

        As part of the  Company's new business  plan,  on November 2, 1998,  the
Company  entered into a Plan and  Agreement of  Reorganization  ("Reorganization
Agreement")   with  Kafus   Industries  Ltd.   ("Kafus"),   a  British  Columbia
corporation.  Under the  Reorganization  Agreement,  the Company issued to Kafus
20,000,000  shares of its Common Stock in exchange for all of the Common  Shares
of Camden Agro-Systems Inc. ("Camden"), an Ontario corporation,  owned by Kafus.
Prior  to the  reorganization,  Kafus  owned  9,000  common  shares  of  Camden,
constituting  90% of  Camden's  outstanding  common  shares.  As a result of the
reorganization,  Kafus owns  approximately  72.6% of the  Company's  outstanding
shares of Common Stock and the Company's  primary  business  interest is Camden.
Unless  otherwise  indicated,  reference to "Hyaton" or the "Company" shall mean
Hyaton Organics Inc. and its wholly-owned subsidiary, Camden Agro-Systems Inc.

        Further,  as  part  of the  Reorganization  Agreement,  the  Company  is
required  to  issue  one  additional  common  share to  Kafus  for each  $.20 of
aggregate  earnings before  interest,  taxes,  depreciation  and amortization of
Camden  accumulated  during  the  period  beginning  on  the closing date of the

<PAGE>3

reorganization  and ending upon the  earlier of: (a) two years from  November 2,
1998, or (b) eighteen months from the commencement of commercial operations by a
Camden plant.

Camden Agro-Systems Inc.

        The Company's  primary  asset is its interest in Camden,  and all of the
Company's  operations  are conducted by Camden.  Camden is a  development  stage
company  that  intends  to  develop  turnkey  facilities  capable  of  producing
organic-based  fertilizers  from animal residues such as hog and poultry manure.
Prior to January 1999,  Camden also was planning the  development  of facilities
for the production of animal feed from food waste.

        Camden  Agro-Systems  Inc. was  incorporated  under the Ontario Business
Corporation  Act (1982) on  November  24,  1994,  for the  purpose  of  business
management,  consulting  and  product  development.  For at least the past three
years,  Camden  has  primarily  focused  its  business  on  the  development  of
converting  organic  waste into animal  feed and animal  residues  into  organic
fertilizer. Camden believes that there are environmental pollution concerns from
animal  residues.   Many   governmental   authorities  are  invoking   stringent
environmental laws and regulations  regarding  pollution,  contamination and the
accumulation  and disposal of waste  products  such as animal  residues.  Camden
believes that it is developing a waste management  process by reducing pollution
in ground and surface waters and by providing a valuable source of nutrients and
organic material for plant production.

         Since February  1998,  Camden had been operating a pilot program for an
organic waste processing  facility at Bartow,  Florida (the "Bartow Plant").  At
the Bartow Plant,  Camden processed organic waste supplied by dairy,  bakery and
ice cream makers into animal feed supplements.  During the pilot program, Camden
entered into an exclusive marketing distribution agreement with Miracle Feeds of
Canada,  Ltd.,  whereby  Miracle  Feeds of Canada  agreed,  subject  to  certain
conditions,  to purchase  all of Camden's  animal  feed  supplement  produced by
Camden at its Bartow  Plant.  In light of the  agreement  with Miracle  Feeds of
Canada, Camden began to upgrade its Bartow Plant to full commercial  production.
At full  production,  the  Bartow  Plant  would have been  capable of  producing
approximately 22,000 short tons of animal feed per year. In addition, Camden was
negotiating a product buy-out agreement with an animal feed supplier, and was in
the planning stages for an animal feed plant in Lakeland, Florida.

        In January 1999, Camden decided to discontinue its animal feed from food
waste program to concentrate its energy and resources on its organic  fertilizer
products.  In light of its limited  capital and resources,  Camden believed that
the organic  fertilizer  market,  which is larger  than the animal feed  market,
provided it a better and faster opportunity to earn revenues.  Further,  because
Camden's  proposed  animal  feed  processing  may be subject to  duplication  by
competitors, this could have the effect of increasing Camden's competitors. As a
result of this decision, Camden allowed its lease at the Bartow Plant to expire,
and ceased all animal feed research and development  including its operations at
the  Bartow  Plant and  proposed  construction  project  in  Lakeland,  Florida.
Notwithstanding  its current direction,  the Company may, in the future,  resume
the development of animal feed from organic waste.

        Organic Fertilizer Products

        Since its redirection in January 1999,  Camden has focused on developing
organic  fertilizer  products  from animal  residues.  Camden  believes that the
organic  fertilizer  market  provides  great  potential for the sale of Camden's
organic  fertilizers,  and justified the continued  research and  development of
proprietary organic fertilizers.  Since 1996, Camden has been collaborating with

<PAGE>4

experts in crop science, animal sciences,  agronomy,  fertilizers, and equipment
manufacturers to research and test its organic  fertilizer  process and proposed
products in Canada, the United States and abroad.

        In 1998,  Camden narrowed its organic  fertilizer  research by selecting
organic waste  materials,  such as animal  residues  that have been  aerobically
processed  under  specific,   optimally  controlled  conditions.  The  resulting
materials have then been used to manufacture three new products.  These products
were initially marketed under the brand VERDANT ORGANIC. However in 1999, Hyaton
applied  for TRULY  ORGANIC(TM)  as its  trademark  in the United  States.  This
application is currently pending. These proposed products are as follows:

     o    Pure Organic Fertilizer Blends, to be marketed as TRULY ORGANIC(TM)MTO
          series,  are a basic  product from which all other  Camden  fertilizer
          formulas will be based upon. They are designed to supply nitrogen (N),
          phosphorus   (P),   and  potash  (K)  to  plants  as   required  on  a
          bio-modulated  release  basis.  The  composition  of the Pure  Organic
          Fertilizer  Blends is designed to restore and  maintain  soil  organic
          matter quality and quantity,  to improve soil aggregation and porosity
          to  increase  water  infiltration  and  retention,  to enhance gas and
          cation exchange,  to improve root growth, and to reduce water and wind
          erosion;

     o    Enhanced  Organic   Fertilizer   Blends,   to  be  marketed  as  TRULY
          ORGANIC(TM)  MTE series,  are organic in origin,  then  enhanced  with
          chemical  nutrients.  The chemical  nutrients are added to the organic
          blend to meet individual crop requirements such as radishes,  lettuce,
          and tomatoes; and

     o    Growing Media, to be marketed as TRULY ORGANIC(TM) GROWING MEDIA, is a
          new  proposed  product  line that can be used as a  substrate  for the
          cultivation of greenhouse  plants, a potting soil or a soil supplement
          to home gardens.  This product line is  manufactured  from organic raw
          materials which contain sufficient  naturally-occurring  quantities of
          nitrogen,   phosphorus,   potash  and  other  essential  elements  for
          commercial plant growth.

        Camden plans to market Camden's organic fertilizer  products by engaging
compatible  corporate  partners to market and distribute its organic  fertilizer
products   as  well  as  large   volume   end   users   and   home  and   garden
distributors/retailers.

        As part of its business redirection, Camden is proposing to develop a 52
acre organic fertilizer  facility located in North Carolina.  Camden proposes to
convert organic  fertilizer  from animal  residues  acquired from local farmers.
Camden intends to use its process originally  developed at the Bartow Plant as a
template for creating  similar  organic  fertilizer  facilities  utilizing their
modular design and manufacturing process.  Camden has filed a patent application
in the United States for this process.  See "Camden  Agro-Systems Inc. - Patents
and Trademarks."

        The Camden Agro-System Process

        The Camden  process is a  procedure  in which  animal  residues  such as
poultry and hog manure is treated and  recycled  into organic  fertilizers.  The
principal steps are (a) receipt and mixing of the organic waste  materials,  (b)
aerobic  processing (which is similar to composting),  (c) mixing the composting
material  with  plant  nutrients, and (d) post aerobic processing and packaging.

<PAGE>5

        Camden intends to exploit its process by establishing organic fertilizer
manufacturing  facilities  internationally.  In  order to meet  this  objective,
Camden believes that it must:

     o    Enter into long-term,  supply agreements from organic waste generators
          such as farmers in the case of animal waste;

     o    Use its proprietary manufacturing process; and

     o    Enter into long-term  marketing and product  buy-out  agreements  from
          reputable companies.

        Camden  believes  that its  proposed  organic  fertilizer  manufacturing
facilities  can be  developed  worldwide.  In  determining  an area  that may be
conducive to one of Camden's facilities, Camden considers the following:

        1.     Identification of those areas that have documented  organic waste
               management  problems,  and can  generate  sufficient  volumes  of
               animal residues to sustain an organic fertilizer operation;

        2.     Active industry associations that are willing to work with Camden
               in  identifying  solutions  for  organic  waste  such  as  animal
               residues; and

        3.     Active local and state  governments that are willing to work with
               Camden in identifying  solutions for organic waste such as animal
               residues.

        In applying the above  criteria,  Camden has selected  North Carolina as
its first proposed organic  fertilizer  processing plant.  During the evaluation
process,  Camden  noted that the state of North  Carolina  had a large number of
both poultry and hog producers,  had active state and national  associations for
poultry and hog producers,  provides  incentives to poultry  producers to remove
animal  residues  through a  secondary  process  or where  land  application  is
avoided,  and had a mild climate that allowed  year-round  plant  operations and
allowed animal  residue  transportation  without damage due to weather,  such as
freezing.

        On May 19,  1999,  Camden  entered  into a letter of  intent to  acquire
approximately 52 acres in Merry Hill, North Carolina.  The property is currently
permitted as a composting  facility and Camden intends to retrofit it to convert
animal residues into organic fertilizer products. The proposed purchase price is
approximately  $750,000 to be paid in part by cash and the assumption of certain
debt. The letter of intent expired October 15, 1999, but Camden has extended the
deadline upon the payment of $10,000. However, Camden and the owner are still in
discussion  regarding  the  acquisition.  Camden has  obtained an  environmental
permit and  construction  permit for the Merry Hill site. The acquisition of the
property is subject to Camden, through the Company,  raising sufficient funds to
pay for the property  and no assurance  can be given that Camden will be able to
complete the acquisition.

        On February 15, 2000,  Hyaton  entered  into a purchase  agreement  with
Furst-McNess  Company under which Furst-McNess shall have the right to purchase,
promote,  market and distribute Hyaton's  fertilizers and growing media produced
at its proposed Merry Hill, North Carolina facility.  The purchase price for the
products  will be  equal  to the  net  selling  price  to the  end  user  less a
percentage to Furst- McNess. The amount of the percentage will be based upon the
net  selling  price.  The  term  of  the agreement will continue until the fifth

<PAGE>6

anniversary  of the final  completion  date of the Merry  Hill,  North  Carolina
facility, subject to extension and is subject to certain conditions.

        Research and Development

        Camden has conducted its research and  development in  conjunction  with
universities and governmental  agencies. In 1996, Camden conducted two livestock
feeding and fertilizer  trials at Kansas State  University,  Kansas.  During the
process,  several short tons of organic waste were  processed into two livestock
feed supplements and one organic-based  fertilizer.  The livestock feeding trial
conducted  by Kansas  State  University  involved  70 heads of  cattle,  and the
fertilizer  trial  consisted of comparing  grain  sorghum  yields in a series of
replicated field plots. The trials indicated that animal residues can be used as
a supplement to livestock  feed and that animal  residues used in  organic-based
fertilizers could exceed commercial fertilizers in yield/acre.

        More recently,  between  September 1998 and February  1999,  Camden,  in
cooperation  with the Eastern Cereal & Oilseed  Research  Centre,  a Division of
Agriculture and Agri-food Canada,  Ottawa,  Ontario,  conducted a joint research
project  assessing  the  physical,  chemical and  agronomic  characteristics  of
Camden's organic  fertilizer  blends and growing media,  TRULY  ORGANIC(TM) MTO,
TRULY ORGANIC(TM) MTE, and TRULY ORGANIC(TM) GROWING MEDIA. The research project
compared  Camden's organic  fertilizer blends and growing media with traditional
growing  media and  chemical  fertilizers.  Tests were  conducted on three major
types of crops: a leafy crop (lettuce);  a root crop (radish);  and a fruit crop
(tomato).  Results of the trials  indicated  that the  performance  of  Camden's
organic fertilizer blends met or exceeded that of traditional fertilizers.

        Agriculture and Agri-food Canada is a Canadian  governmental agency that
promotes the development,  adaptation and competitiveness of the agriculture and
agri-food  sector  through  policies  and programs  that are most  appropriately
provided by the  Canadian  federal  government.  The overall goal is to help the
sector  maximize  its  contribution  to  Canada's   economic  and  environmental
objectives  and achieve a safe,  high quality food supply  while  maintaining  a
foundation  for  agriculture.  Since  1997,  Camden has  expended  approximately
$200,000 for research and  development of its organic  products,  and Camden has
committed  an  additional  Cdn  $60,000  for  comparative  testing  and  further
development  of its  organic  fertilizer  blends at  Agriculture  and  Agri-food
Canada.

        The development of Camden's organic fertilizers blends and growing media
is in its initial stages.  No assurance can be given that Camden will be able to
produce the same test results under commercial production conditions.

        Sources and Availability of Raw Materials

        Camden's  main  source  of raw  materials  for  its  organic  fertilizer
products will be animal residues initially  consisting of poultry manure and hog
manure.  Camden  believes  that  there is a great  supply of these  ingredients.
Camden  intends to enter  into  by-products  supply  agreements  with  initially
poultry and hog farmers located in North Carolina.  Under the by-products supply
agreement,  the farmers will supply Camden with animal residues  meeting certain
specifications.  Camden  will pay the farmer for the  animal  residues  with the
right to receive any state  incentives for the disposal of the animal  residues.
Due to the  increase  in  organic  waste  material,  some  states  such as North
Carolina provide  incentives  and/or subsidies to companies that recycle organic
waste.

<PAGE>7

        Customers

        At this  time,  because  Hyaton  is in the  development  stage it has no
customers.   However,   Hyaton  has  entered  into  a  purchase  agreement  with
Furst-McNess  Company under which  Furst-McNess will purchase products of Hyaton
subject to certain conditions.

        Competition

        Camden is directly and indirectly in competition  with other  fertilizer
businesses,  including  other organic  recycling  facilities.  Further,  many of
Camden's  competitors  have greater  production  capacity and greater  financial
resources  and,  therefore,  may be better able to compete in the  domestic  and
international  markets.  Competing technology may also be developed by the other
companies in the industry. Further, many of Camden's competitors may take action
such as price  reductions to keep their markets and hinder  Camden's  ability to
sell its products. There can be no assurance that Camden will be able to develop
a competitive position in the fertilizer industry.

        Patents and Trademarks

        In the course of Camden's ongoing organic  fertilizer  research,  it has
developed  various  technological  innovations  in the  areas  of  manufacturing
process as well as products.  At June 24, 1999, the Minister of Agriculture  and
Agri-food  Canada on behalf of Camden  applied for patents in the United  States
for its three product lines: Pure Organic  Fertilizer  Blends,  Enhanced Organic
Fertilizer Blends,  and Growing Media.  Collectively,  the applications  include
composition claims for its organic fertilizers and manufacturing  processes.  In
conjunction with the evaluation of Camden's organic  products,  the patents were
transferred to Camden. These patent applications are currently pending.

        No assurance  can be given that Camden's  manufacturing  process will be
granted  a  patent,  or if  granted,  that it  will  afford  protection  against
competitors.   Further,  any  patent  issued  to  Camden  could  be  challenged,
invalidated or circumvented by others. Further, since patent applications in the
United  States  are  maintained  in secrecy  until the patent is issued,  Camden
cannot be certain that others have not filed patent applications directed toward
inventions  covered by its pending patent  applications or that it was the first
to file patent  applications on such inventions.  There can also be no assurance
that any  application  of Camden's  technologies  will not  infringe  patents or
proprietary  rights  of others  or that  licenses  that  might be  required  for
Camden's  processes  or products  would be available on  reasonable  terms.  The
extent to which Camden may be required to obtain licenses from others,  the cost
and the availability of such licenses are unknown.

        Camden also makes use of its trade  secrets or  "know-how"  developed in
the course of its research and development in the area of manufacturing process.
To the extent that Camden relies upon trade secrets, unpatented know-how and the
development  of  improvements  in  establishing  and  maintaining  a competitive
advantage in the market for Camden's  products,  there can be no assurances that
such  proprietary  technology will remain a trade secret or that others will not
develop substantially equivalent or superior technology to compete with Camden's
products.

        Hyaton has filed a trademark for "TRULY  ORGANIC" in the United  States.
The trademark is currently pending.

<PAGE>8

        If Camden  becomes  involved in litigation  regarding  its  intellectual
property,  it could consume a substantial portion of Camden's resources.  Camden
may lack the financial  resources to defend its intellectual  property claims or
to prosecute infringements by others.

Environmental Regulations

        The  location,   construction,   and  operation  of  organic  fertilizer
facilities  are  regulated by state and federal  environmental  laws.  Obtaining
local  approvals and state air,  water and  operating  permits is a detailed and
complex process.  This may especially be true where the proposed  facility is to
be located in or near urban  areas.  Requisite  approvals to be obtained in most
jurisdictions include Local Planning Board, Zoning Boards, Solid Waste and Water
Disposal Boards, Composting Operation Permits, Air Permits and Building Permits.
Recently,  Hyaton  received an  environmental  permit at its  proposed  facility
located in Merry Hill, North Carolina.

Employees.  As of December 31, 1999, the Company,  and its subsidiary,  had five
consultants and one employee.

                             CERTAIN CONSIDERATIONS

        In addition to the other  information  presented  herein,  the following
should be considered carefully in evaluating the Company and its business.  This
information   contains   forward-looking   statements  that  involve  risks  and
uncertainties.  The  Company's  actual  results may differ  materially  from the
results discussed in the  forward-looking  statements.  Factors that might cause
such a difference  include,  but are not limited to, those  discussed  below and
elsewhere herein.

        Lack of Profits and Going Concern  Opinion.  For the year ended December
31, 1999, the three months ended December 31, 1998, and year ended September 30,
1998,  the Company  incurred  net losses of  $739,192,  $126,131  and  $268,548,
respectively.  As a  result  of  these  losses  and  negative  cash  flows  from
operations,  the  Company's  auditors'  report  on  the  Company's  consolidated
financial   statements   include  an  additional   paragraph   which  refers  to
uncertainties  as to the  Company's  ability to  continue  to operate as a going
concern.

        Development  Stage  Company.   Hyaton  is  in  its  development   stage,
researching  and  developing  organic-based  fertilizers.  The  Company  has  no
commercial  products.  Although under test  conditions,  the Company's  proposed
organic fertilizers  performed as well, if not better, than traditional chemical
fertilizers,  no assurance can be given that the Company will be able to achieve
the same results under commercial conditions. Further, Hyaton will face the same
challenges experienced by other development stage companies,  including, but not
limited to, developing market acceptance for its proposed products.

        Need for  Additional  Capital.  The Company  believes  that it will need
additional working capital to finance and develop organic fertilizer  facilities
and for its  operations in 2000. No assurance can be given that the Company will
be successful in raising capital for its projects or, if raised, that it will be
on terms favorable to the Company. In the event the Company is required to raise
additional  capital through  private  placement of its equity  securities,  such
placement  of equity  securities  will  have the  effect  of  diluting  existing
shareholders'  ownership  interest in the  Company.  If the Company is unable to
raise sufficient funds to finance these projects, the Company may not be able to
complete  its  projects  which  will have an  adverse  effect  on the  Company's
business objectives.

<PAGE>9

     Dependence  on Key  Personnel.  The  Company  is  dependent  on Mr.  Robert
Novitsky,  President,  for his expertise.  The loss of Mr. Novitsky could have a
material adverse effect upon the Company.

     Concentration  of Stock  Ownership.  As of December 31,  1999,  Kafus owned
20,000,000  shares of Common  Stock of the  Company  constituting  approximately
72.6% of the outstanding  shares. As a result of its ownership,  Kafus will have
substantial  control over corporate  matters without  seeking other  shareholder
approval,  including  the  election of  directors  and  approval of  significant
corporate  transactions.  Further, such concentration of ownership may also have
the effect of delaying or preventing a change in control of the Company.

     Authorization of Preferred Stock; Possible Anti-Takeover Effects. The Board
of  Directors  is  authorized  to issue  Preferred  Stock and to  determine  the
dividend, liquidation, conversion, redemption and other rights, preferences, and
limitations of such shares without  further vote or action of the  stockholders.
Accordingly,  the Board of Directors is empowered, without shareholder approval,
to issue  Preference  Stock with  dividend,  liquidation,  conversion,  or other
rights  which  could  adversely  affect  the  voting  power or the rights of the
holders of the Common Stock. In the event of such issuance,  the Preferred Stock
could be utilized, under certain circumstances,  as a method of discouraging and
delaying or preventing a change in control of the Company.

     No Dividends.  The Company has not paid cash  dividends on its Common Stock
since its inception  and does not  anticipate  any cash  dividends on the Common
Stock in the foreseeable future. For the foreseeable future, the Company intends
to  reinvest  the  earnings  of the  Company,  if any,  in the  development  and
expansion of its business.

Item 2.  Description of Property

     The Company,  through Camden,  leases 900 square feet of office space in an
office building located at 2285 St. Laurent Boulevard, Unit 16, Ottawa, Ontario,
Canada.  The  lease  has no fixed  terms  and may be  terminated  within 30 days
written notice. The Company pays a monthly rent of approximately CDN $1,700.

Item 3. Legal Proceedings

     Neither the Company nor Camden is involved in any legal proceeding.

Item 4.  Submission of Matters to a vote of Security Holders

     None

Item 5.  Market for common equity and Related Stockholder Matters

     The Company's  Common Stock began  trading on the OTC Bulletin  Board under
the symbol  "HYTN" on September 30, 1998.  The Company has a limited  market for
its Common Stock with no real trading volume.  The following  quotations reflect
inter-dealer prices, without retail mark-up, mark-down or commission and may not
represent actual  transactions.  The high and low prices of the Company's Common
Stock on a quarterly basis since September 30, 1998, are as follows:

<PAGE>10

Quarter Ended                    High              Low
- -------------                    ----              ---
December 31, 1999               $3.25             $2.00
September 30, 1999              $2.00             $2.00
June 30, 1999                   $2.50             $1.75
March 31, 1999                  $3.00             $1.50
December 31, 1998               $2.00             $0.19


Item 6.  Management's Discussion and Analysis or Plan of Operation

General

        The following discusses the Company's financial condition and results of
operations based upon the Company's consolidated financial statements which have
been prepared in accordance with generally accepted accounting principles.

        The Company was formed on August 20, 1996,  to evaluate  businesses  for
possible  acquisition.  Effective  November  2, 1998,  the  Company  completed a
reorganization  with Kafus whereby the Company issued  20,000,000  shares of its
Common  Stock in exchange  for Kafus'  9,000  common  shares of Camden.  Through
Camden,  the Company is in the  business of  management  consulting  and product
development, and the Company's efforts have focused primarily on the development
of organic fertilizers from animal waste.

        During fiscal year 1998, the Company changed its year end from September
30 to December 31. The following  information discusses the Company's results of
operations  for the year ended December 31, 1999, and for the three months ended
December  31,  1998.  Because  the  Company  is in the  development  stage,  the
following financial information is not indicative of the Company's operations in
the future.

Results of Operations

For the year ended December 31, 1999

        Revenues. For the year ended December 31, 1999, the Company had revenues
of $39,253.

        Expenses. Total  expenses for  the year ended  December  31, 1999,  were
$778,445.  Most of the expenses  consisted of consulting and  professional  fees
related to the development of the Company's organic  fertilizers and for product
development and research  costs.  Included in total expenses was employee equity
compensation of $222,500.

        Net Loss. The Company incurred a net loss of $739,192 for the year ended
December 31, 1999, primarily related to the lack of revenues.

<PAGE>11

For the three months ended December 31, 1998

        Revenues.  Revenues for the three months  ended  December 31, 1998, were
$36,465.  Revenues  were  primarily  derived  from  contract  services regarding
environmental studies.

        Expenses.  Total  expenses for the three months ended December 31, 1998,
were $162,596,  consisting  primarily of consulting and other professional fees,
product  development and research costs and  administrative  and other expenses.
Consulting fees related to engineer and administrative  services provided to the
Company.  Product  development  and  research  costs  relate  primarily  to  the
development  of organic  animal feed from organic waste and organic  fertilizers
from animal residues,  patent  applications for organic  fertilizers and project
costs for consulting  services  rendered.  As previously  discussed,  during the
beginning  of 1999,  the Company  began to  concentrate  its efforts  toward the
development of organic fertilizers from animal residues.

        Net Loss.  The  Company  had a net loss of $126,131 for the three months
ended December 31, 1998.

Year ended September 30, 1998 compared to Year ended September 30, 1997

        Revenues.  Revenues for the year ended  September 30, 1998,  were $2,805
compare to no revenues  for the year ended  September  30, 1997.  Revenues  were
primarily derived from contract services regarding environmental studies.

        Expenses.  Total  expenses for the year ended  September 30, 1998,  were
$271,353  compared to total expenses of $22,059 for the year ended September 30,
1997. During the year ended September 30, 1998, expenses increased substantially
in consulting and other  professional  fees,  product  development  and research
costs and administrative and other expenses. Consulting fees related to engineer
and  administrative  services provided to the Company.  Product  development and
research  costs relate  primarily to the  development of organic animal feed and
fertilizers from animal residues.

        Net Loss. For the year ended  September 30, 1998, the Company had a loss
of $268,548 compared to a loss of $22,059 for the year ended September 30, 1997.
The  substantial  loss incurred during the year ended September 30, 1998, can be
attributed to the increase in total expenses  related to the  development of the
Company's proposed products.

Liquidity and Capital Resources

        The Company is a  development  stage company that intends to develop and
market fertilizer derived from animal residues. At this time, the Company has no
substantial revenues,  and does not anticipate any substantial revenues until it
is able to develop and sell its products.  Previously,  the Company has received
loans to fund its operations and provide working capital. It is anticipated that
the Company will continue to finance its operations through loans and equity and
debt financings.  As of December 31, 1999, the Company's working capital deficit
was $15,109 and as of December  31,  1998,  the  Company's  working  capital was
$12,029.

<PAGE>12

Impact of the Year 2000 Issue

        The Year 2000 Issue is the result of  computer  programs  being  written
using two digits  rather  than four to define the  applicable  year.  Any of the
Company's,  or  its  suppliers'  and  customers'  computer  programs  that  have
date-sensitive  software may recognize a date using "00" as the year 1900 rather
than the year 2000.  This could  result in system  failures  or  miscalculations
causing  disruptions of operations  including,  among other things,  a temporary
inability to process  transactions,  send invoices,  or engage in similar normal
business activities.

        Because the Company is in the  development  stage and has no significant
operations,  the  Company  does not  anticipate  that its  software  or computer
systems will require any significant  modification or replacement in response to
the Year 2000  Issue.  As of  December  31,  1999,  the Year 2000  Issue did not
materially affect the operations of the Company and its subsidiary.  The Company
will continue to monitor any Year 2000 Issue.

Item 7.  Financial Statements

        The information required by item 310(a) of Regulation S-B is attached to
this Annual Report.

Item 8.  Changes in and Disagreements with Accountants

        None

Item 9.  Directors, Executive Officers, Promoters and Control Persons


                                   MANAGEMENT

Executive Officers and Directors

        The directors  and executive  officers of the Company as of December 31,
1999, are as follows:


<TABLE>
<CAPTION>

           Name                    Age      Office or Position                   Held Position Since
           ----                    ---      ------------------                   -------------------

<S>                              <C>       <C>                                     <C>
Executive Officers and Directors
of the Company:

Robert Novitsky                    52       President, Director                         1999

Manfred Schultz                    51       Vice President of Business                  1999
                                            Development, Director

Michael McCabe                     42       Chief Financial Officer, Director           1998

Peter Schlesinger                  65       Director                                    1999

Milton Datsopoulos                 59       Director                                    1999

Gordon Robinson                    59       Director                                    1999

Paul McClory                       59       Director                                    1999

<PAGE>13

           Name                    Age      Office or Position                   Held Position Since
           ----                    ---      ------------------                   -------------------

Tony Valentine                     38       Director                                    1999

Lynda Murdock                      38       Treasurer                                   1999

Fiama Walker                       55       Secretary                                   1999

Executive Officers of Camden:

Robert Novitsky                    52       President                                   1996

Manfred Schultz                    51       Vice President of Business                  1999
                                            Development

</TABLE>


     The  following  sets forth the principal  occupations  during the past five
years of the  directors  and  certain  executive  officers  of the  Company  and
executives of its subsidiary.

     Robert L. Novitsky has been the President and Director of the Company since
March 1999 and has been with the Company since 1998. Mr.  Novitsky has also been
the President of Camden since 1996. Mr.  Novitsky was a Director of The CanFibre
Group Ltd. from August 1992 to December 1997.  Since 1990, Mr. Novitsky has been
President  and Director of Notra  Environmental  Services Inc. and Notra Marine.
From 1989 to 1990, he was Executive  Vice-President  in charge of management for
Amtek Engineering Service Incorporated,  an engineering consulting company. From
1986 to 1990, he was President of SSI Monenco  Limited and  responsible  for all
corporate activities  associated with that professional  engineering company. He
has a Bachelor  degree in Chemical  Engineering  from Royal Military  College in
Kingston,  Ontario, an Ocean Engineer degree from MIT and a Master of Science in
Materials Engineering and Science from MIT.

     Manfred W. Schultz has been the Vice  President of Business  Development of
the Company  since  September 1, 1999,  and Director of the Company since August
1999. Mr. Schultz has also worked with Camden on a consultative basis since June
1999. From 1995 to 1999, Mr. Schultz worked as a business consultant for various
businesses  and held senior  executive  and  Director  positions  at  Integrated
Resources Corp. and Northern Ostrich Corp. From 1987 to 1995, he founded and was
President  and Chief  Executive  Officer of Koala  Beverages  Ltd.  where he was
responsible for development  and overall  management.  He has a Bachelor of Arts
degree in Economics from the University of Western Ontario.

     Michael  McCabe  has been Chief  Financial  Officer  and a Director  of the
Company  since  1998.  Since  1997,  Mr.  McCabe has served as  President  and a
Director  of Kafus  Industries  Ltd.  From 1996 until May 1997,  Mr.  McCabe was
Managing  Director  of Project  Finance for Key Global  Finance  Ltd. in Boston,
Massachusetts.  From 1991 to 1996,  he was Senior Vice  President of BTM Capital
Corporation.  He  has a BS in  Chemistry  and  Physics  from  Bridgewater  State
College,  an MS in Chemical  Engineering from Purdue  University,  and an MBA in
Finance from Pace University.

     Peter  Schlesinger  has been a Director of the Company  since  August 1999.
Since  December  1993 Mr.  Schlesinger  has been a Director  of, and since March
1998,  Chairman of the Board and Chief Financial  Officer of, MGPX Ventures Inc.
Now self-employed,  Mr.  Schlesinger was a partner of a Canadian  stockbrokerage
firm,  Annett  Partners,  for ten years  and  manager  of a  Bermuda  investment
company, Tatra Ltd., since 1974. He was president of Halton Insurance, a Bermuda

<PAGE>14

insurance company,  listed on The Toronto Stock Exchange, from 1988 to 1994. For
ten years he has also served as  president  of the  Canadian  Parkinson  Disease
Foundation.  Mr. Schlesinger has a BS in Psychology and Economics, and an MBA in
Finance from Columbia University.

     Milton  Datsopoulos  became a Director of the Company on October 15,  1999.
Mr.  Datsopoulos  has also been a director of Kafus since March 25, 1998.  Since
1974, Mr. Datsopoulos has been a partner of Datsopoulos, MacDonald & Lind, P.C.,
attorneys at law.

     Gordon  Robinson  became a Director of the Company on October 15, 1999. Mr.
Robinson has also been a director of Kafus since March 25, 1998. Since 1992, Mr.
Robinson owns and operates a home improvement business.

     Paul  McClory was  appointed to the Board of Directors on October 15, 1999.
He was also director of Kafus from June 11, 1996,  until 1998. For over the past
five years, Mr. McClory, through his wholly-owned company Willow Holdings, Inc.,
has been a consultant to several public and private  companies  including  Kafus
and North American Tire Recycling Ltd.

     Tony  Valentine  became a Director of the Company on October 15, 1999.  Mr.
Valentine has also been a director of Kafus since  February 3, 1999.  Since July
5, 1999, Mr.  Valentine has been  Executive  Vice President and Chief  Financial
Officer of Kafus.  Prior to this time and since 1997,  Mr.  Valentine has been a
Vice President of Enron Capital & Trade Resources  Corp.'s  Industrial  Services
Group in Houston.  From 1993 to 1995,  Mr.  Valentine  was a Vice  President  of
General  Electric  Capital  Services  and  from  1989  through  1993,  he was an
associate with Chase  Manhattan  Bank in New York. Mr.  Valentine was a Chemical
Engineer  with Shell Oil  Company in New Orleans  from 1984  through  1987.  Mr.
Valentine received a Bachelor of Science degree in Chemical Engineering from the
University of Tennessee and an MBA from Harvard Business School.

     Lynda Murdock was  appointed  Treasurer to the Company on October 15, 1999.
Since June 1999, Ms.  Murdock has been Senior Vice President of Taxation,  Audit
and  Accounting for Kafus.  Prior to her time with Kafus,  Ms. Murdock has spent
the last 15 years in public accounting practice,  most recently as a Tax Partner
with KPMG LLP of Canada. Ms. Murdock is a Chartered  Accountant and has a B.Comm
honor's degree from the University of British Columbia.

     Fiama Walker has been  Secretary of the Company  since  September 16, 1999.
Ms. Walker has been Assistant  Corporate  Secretary and Manager of Compliance of
Kafus  since  July 7,  1998.  For the last 25  years,  Ms.  Walker  worked  as a
paralegal  and  legal  assistant  for  various  law firms in  British  Columbia,
specializing in corporate and commercial law. She has completed  diploma courses
in  business  administration,  accounting  and law  from  various  colleges  and
universities in British Columbia.

Item 10.  Executive Compensation

Executive Compensation

     None of the  Company's  directors,  officers,  or employees or officers and
employees  of its  subsidiaries  earned in excess of $100,000 for the year ended
December 31, 1999.

<PAGE>15

        The  following  table  sets  forth  the  compensation  of the  Company's
president during the last fiscal year. No officer  received annual  compensation
in excess of $100,000 during the last fiscal year.

                           SUMMARY COMPENSATION TABLE

<TABLE>
<CAPTION>

                                                                                              Long Term Compensation
                                                                             ------------------------------------------------------
                                           Annual Compensation                         Awards                Payout
                               -------------------------------------------   ---------------------------  -------------
                                                                               Restricted  Securities
                                                           Other Annual           Stock    Underlying         LTIP       All Other
Name and Principal                                         Compensation         Award(s)     Options         Payout      Compensa-
Position                Period     Salary      Bonus ($)        ($)                ($)         (#)             ($)       tion ($)
- --------------------------------------------------------------------------   ---------------------------  -------------------------

<S>                      <C>     <C>           <C>          <C>                <C>        <C>               <C>         <C>
Robert L. Novitsky       1999    $45,767(1)
President                1998    $10,149(2)           -          -                 -            -               -            -


</TABLE>

(1)  Represents  consulting  fees. Mr.  Novitsky does not receive any salary for
     serving as President.

(2)  Mr.  Novitsky has been receiving a salary in the form of consulting fees of
     Cdn $3,383 per month for  serving as the  president  of Camden.  The figure
     $10,149 represents three months' salary.

        At this time,  the Company does not pay its  directors  compensation  as
serving as such and for their  attendance at board  meetings.  Further,  at this
time, the Company does not provide  pension,  retirement or similar  benefits to
its  officers  and  directors.  However,  directors  receive  stock  options  as
compensation.

Outstanding Options Granted to Directors and Executive Officers

        The  following  table  provides  information  relating to share  options
granted to  directors  and  certain  executive  officers  of the Company and its
subsidiary, Camden, as a group, and outstanding as of December 31, 1999.

<TABLE>
<CAPTION>


           Name                 Number of Options      Exercise Price            Expiration Date
           ----                 -----------------      --------------            ---------------
<S>                                <C>                      <C>                <C>
Robert Novitsky                    125,000                  $1.50               October 13, 2004

Michael A. McCabe                   25,000                  $1.50               October 13, 2004

Peter Schlesinger                   25,000                  $1.50               October 13, 2004

Manfred W. Schultz                 100,000                  $1.50               October 13, 2004

Milton Datsopoulos                  25,000                  $1.50               October 13, 2004

Gordon Robinson                     25,000                  $1.50               October 13, 2004

Paul McClory                        25,000                  $1.50               October 13, 2004

Tony Valentine                      25,000                  $1.50               October 13, 2004

Lynda Murdock                       10,000                  $1.50               October 13, 2004

Fiama Walker                        5,000                   $1.50               October 13, 2004

<PAGE>16

           Name                 Number of Options      Exercise Price            Expiration Date
           ----                 -----------------      --------------            ---------------

Officers and Directors as           390,000
a group (9 persons)

</TABLE>

        In addition to the  foregoing,  the Company has granted to its employees
five-year options to purchase,  in the aggregate,  55,000 shares of Common Stock
of the Company at $1.50 per share.

        The  following  table sets  forth the  options  granted to Mr.  Novitsky
during the past fiscal year.

<TABLE>
<CAPTION>

                               OPTION GRANTS IN LAST FISCAL YEAR

                                Individual Grants
                    --------------------------------------------------------------------------------------
                          Number of        % of Total Options
                          Securities           Granted to
                      Underlying Options      Employees in       Exercise or Base
       Name              Granted (#)          Fiscal Year          Price ($/Sh)        Expiration Date
- ----------------------------------------------------------------------------------------------------------

<S>                        <C>                    <C>                   <C>           <C>
Robert Novitsky             125,000                45.5%                 $1.50         October 13, 2004

</TABLE>

        The following table sets forth Mr. Novitsky's fiscal year option values.
No options were exercised by Mr. Novitsky during 1999.


                 AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR
                        AND FISCAL YEAR-END OPTION VALUES

<TABLE>
<CAPTION>
                                                                                          Value of
                                                                                     Unexercised In-the-
                                                          Number of Unexercised at    Money Options at
                                                                 FY-End (#)             FY-End ($)(1)

                      Shares Acquired    Value Realized         Exercisable/            Exercisable/
       Name           on Exercise (#)         ($)              Unexercisable            Unexercisable
- ----------------------------------------------------------------------------------------------------------
<S>                     <C>              <C>              <C>                         <C>
Robert Novitsky             None              None          125,000 Exercisable/       $125,000 /  $0
                                                               0 Unexercisable

</TABLE>

(1)  Market price at November 3, 1999,  the last reported trade for the calendar
     year ended 1999, for a share of common stock was $2.81.

<PAGE>17

Item 11.  Security Ownership of Certain Beneficial Owners and Management


                             PRINCIPAL SHAREHOLDERS

        The  following  table sets  forth,  as of  December  31,  1999,  certain
information  with respect to the  beneficial  ownership of the Company's  Common
Stock by (a) each stockholder known by the Company to be the beneficial owner of
more than 5% of the  Company's  Common  Stock,  (b) each  executive  officer and
director of the  Company,  and (c) each  director and  executive  officer of the
Company and its subsidiary as a group.
                                                              Percentage
                                           Number of         Beneficially
Name and Address                           Shares(1)             Owned
- ----------------
Kafus Industries Ltd.                     20,000,000              72.6%
1500 West Georgia Street 13th Floor
Vancouver, British Columbia
Canada   V6G 2Z6
Robert Novitsky                              245,000(2)              *
Manfred Schultz                              100,000(3)              *
Michael McCabe                                25,000(3)              *
Peter Schlesinger                             25,000(3)              *
Milton Datsopoulos                            25,000(3)              *
Gordon C. Robinson                            25,000(3)              *
Paul McClory                                  25,000(3)              *
Tony Valentine                                25,000(3)              *
Lynda Murdock                                 10,000(3)              *
Fiama Walker                                   5,000(3)              *
All directors and executive officers as a    510,000(3)            1.7%
group (9 persons)


*       Represents less than 1%.

(1)     Except as otherwise indicated,  the Company believes that the beneficial
        owners of the Common Stock listed above, based on information  furnished
        by such owners,  have sole  investment  and voting power with respect to
        such  shares,  subject to  community  property  laws  where  applicable.
        Beneficial  ownership is determined in accordance  with the rules of the
        Securities  and Exchange  Commission  and generally  includes  voting or
        investment  power with  respect to  securities.  Shares of Common  Stock
        subject to options or warrants  currently  exercisable,  or  exercisable
        within 60 days,  are deemed  outstanding  for purposes of computing  the
        percentage ownership of the person holding such option or warrants,  but
        are not deemed  outstanding  for  purposes of computing  the  percentage
        ownership of any other person.

<PAGE>18

(2)  As of December 31, 1999,  Mr. Robert  Novitsky  holds an option to exchange
     his ten percent (10%) interest in Camden (which  represents 1,000 shares of
     Camden's  common shares) for 120,000 shares of the Company's  Common Stock.
     See "Item 12. Certain Relationship and Related Transactions." Also includes
     options to purchase 125,000 shares of Common Stock.

(3)  Represents options  exercisable within 60 days to purchase shares of Common
     Stock.

Item 12.  Certain Relationships and Related Transactions

        In  connection  with the  Reorganization,  Mr.  Novitsky and the Company
entered  into an  agreement  pursuant  to which Mr.  Novitsky  has the option to
exchange his 1,000 shares in Camden,  representing 10% of the outstanding Camden
common shares, for 120,000 shares of Common Stock of the Company.

        The Company pays rent for office space to Notra  Environmental  Services
Inc. of which Mr. Robert L.  Novitsky is also the President and a Director.  Mr.
Novitsky is also the  President  and director of the Company,  the  President of
Camden,  and a minority  shareholder  of Camden,  owning  ten  percent  (10%) of
Camden.  For the year ended  December 31,  1999,  and for the three months ended
December  31,   1998,   the  Company  paid  rent  of  $13,730  and  Cdn  $5,100,
respectively.

        As at December 31, 1999 and  December  31,  1998,  the Company had loans
outstanding  in the  aggregate  amount of $900,710 and $373,605 due to Kafus and
its  affiliates.  The loans are  non-interest  bearing with no specific terms of
repayment.

Item 13.  Exhibits and Reports on Form 8-K

(a)    Exhibits

     2.1  Plan and Agreement of Reorganization,  dated November 2, 1998, between
          the Company and Kafus Environmental Industries Ltd.(1)

     3.1  Amended and  Restated  Articles  of  Incorporation  of Hyaton  Company
          Incorporated (1)

     3.2  Amended  Articles  of  Incorporation  of Hyaton  Company  Incorporated
          changing its name to Hyaton Organics Inc.(1)

     3.3  Amended and Restated Bylaws of the Company (1)

     10.1 Option   Agreement   between   Robert   Novitsky  and  Hyaton  Company
          Incorporated(2)

     10.2 Purchase  Agreement with  Furst-McNess  Company (portions of which are
          deemed confidential and have been omitted)

     27.1 Financial Data Schedule

(1)  Previously filed with the Company's Form 10-SB on October 28, 1999.

(2)  Previously  filed with the Company's Form 10-SB amendment no. 1 on November
     10, 1999.

(b)    Form 8-K

       None

<PAGE>19

                                   SIGNATURES

        In  accordance  with  Section  13 or  15(d)  of the  Exchange  Act,  the
registrant  caused  this  report to be signed on its behalf by the  undersigned,
thereunto duly authorized.

                                                   HYATON ORGANICS INC.



Dated: March 27, 2000                              /s/   Robert Novitsky
                                               By: Robert Novitsky, President


        In  accordance  with the Exchange Act, this report has been signed below
by the following  persons on behalf of the  registrant and in the capacities and
on the dates indicated.


/s/ Robert Novitsky                               Dated:   March 27, 2000
Robert Novitsky, President and Director

/s/ Manfred Schultz                               Dated:   March 28, 2000
Manfred Schultz, Vice President and
Director

/s/ Michael McCabe                                Dated:   March 28, 2000
Michael McCabe, Chief Financial Officer
and Director

/s/ Peter Schlesinger                             Dated:   March 27, 2000
Peter Schlesinger, Director

/s/ Milton Datsopoulos                            Dated:   March 29 2000
Milton Datsopoulos, Director

/s/ Gordon Robinson                               Dated:   March 27, 2000
Gordon Robinson, Director

/s/ Paul McClory                                  Dated:   March 27, 2000
Paul McClory, Director

<PAGE>F-1



Auditors' Report

To the Shareholders and Board of Directors
Hyaton Organics Inc.
  (formerly Hyaton Company Incorporated)


We have  audited the  consolidated  balance  sheets of Hyaton  Organics  Inc. (a
development  stage  enterprise)  as at  December  31,  1999  and  1998  and  the
consolidated  statements of  operations  and deficit and cash flows for the year
ended  December 31, 1999,  the three month period ended  December 31, 1998,  the
year  ended   September   30,  1998  and  the  period  from  November  24,  1994
(incorporation)   through  December  31,  1999.  These  consolidated   financial
statements   are  the   responsibility   of  the   Company's   management.   Our
responsibility  is  to  express  an  opinion  on  these  consolidated  financial
statements based on our audits.

We conducted our audits in accordance with generally accepted auditing standards
in the  United  States of  America.  Those  standards  require  that we plan and
perform the audit to obtain  reasonable  assurance  about  whether the financial
statements are free of material misstatement.  An audit includes examining, on a
test basis,  evidence  supporting  the amounts and  disclosures in the financial
statements.  An audit also includes assessing the accounting principles used and
significant  estimates  made by  management,  as well as evaluating  the overall
financial  statement  presentation.   We  believe  that  our  audit  provides  a
reasonable basis for our opinion.

In our opinion, the consolidated  financial statements referred to above present
fairly, in all material  respects,  the financial  position of the Company as at
December 31, 1999 and the results of its  operations  and its cash flows for the
year ended  December 31, 1999,  the three month period ended  December 31, 1998,
the year  ended  September  30,  1998 and the  period  from  November  24,  1994
(incorporation)  through December 31, 1999 in accordance with generally accepted
accounting principles in the United States of America.

The accompanying  consolidated  financial statements have been prepared assuming
that the Company will continue as a going concern.  As discussed in note 1(a) to
the  consolidated  financial  statements,  the Company is  dependent  on raising
financing to fund the construction of a manufacturing  facility for its patented
fertilizer  products and the  attainment  of  profitable  operations  that raise
substantial doubt about its ability to continue as a going concern. Management's
plans in this regard are also described in note 1(a).  The financial  statements
do not  include  any  adjustment  that  might  result  from the  outcome of this
uncertainty.



(signed) "KPMG LLP"

Chartered Accountants


Vancouver, Canada

March 23, 1999


<PAGE>F-2


HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)
(a development stage enterprise)

Consolidated Balance Sheets
(expressed in U.S. dollars)

December 31, 1999, with comparative figures for 1998

<TABLE>
<CAPTION>


                                                                 1999              1998
                                                             ------------      -----------
<S>                                                         <C>               <C>
Assets

Current assets:
  Cash                                                       $      3,218      $     9,210
  Accounts receivable and other                                    11,887           41,108
                                                             ------------      -----------
  Total current assets                                             15,105           50,318

Computer equipment, net of accumulated depreciation
  of $885 (1998 - $394)                                             1,084            1,474
                                                             ------------      -----------
Total assets                                                 $     16,189      $    51,792
                                                             ============      ===========
Liabilities and Shareholders' Deficiency

Current liability:
  Accounts payable and accrued liabilities (note 3)          $     30,214      $    38,289

Loans from related parties (note 3)                               940,850          412,811
                                                             ------------      -----------
Total liabilities                                                 971,064          451,100

Shareholders' deficiency:
  Capital stock (note 4):
    Authorized:
      100,000,000 common shares with a par value of $0.01
      25,000,000 preference shares with a par value of $0.01
    Issued:
      27,556,000 common shares (1998 - 27,559,000)                275,560          276,247
    Additional paid-in capital                                    223,187                -
    Deficit accumulated during the development stage           (1,430,962)        (691,770)
    Other comprehensive income (note 5):
      Cumulative translation adjustment                           (22,660)          16,215
                                                             ------------      -----------
    Total shareholders' deficiency                               (954,875)        (399,308)

Contingencies (notes 1(a) and 6)
                                                             ------------      -----------
Total liabilities and shareholders' deficiency               $     16,189      $    51,792
                                                             ============      ===========

</TABLE>

See accompanying notes to consolidated financial statements.


<PAGE>F-3

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)
(a development stage enterprise)

Consolidated Statements of Operations and Deficit
(expressed in U.S. dollars)


<TABLE>
<CAPTION>

                                                                                          For the period
                                                              Three month                   November 24,
                                               Year ended    period ended    Year ended       1994 to
                                               December 31,   December 31,  September 30,   December 31,
                                                  1999           1998           1998            1999
                                             --------------  -------------  -------------  --------------

<S>                                          <C>             <C>            <C>            <C>
Revenue                                      $     39,253    $     36,465   $       2,805  $       87,666

Expenses (note 3):
    Consulting and other professional fees        356,021          69,692          97,504         541,333
    Product research and development
      costs                                       131,686          64,092         126,770         325,086
    Travel                                         12,488           1,389          22,083          41,980
    Administrative and other expenses              55,750          27,423          24,996         117,139
    Employee equity compensation                  222,500               -               -         222,500
                                             ------------    ------------   -------------  --------------
                                                  778,445         162,596         271,353       1,248,038
                                             ------------    ------------   -------------  --------------
Net loss                                          739,192         126,131         268,548       1,160,372

Deficit accumulated during the
  development stage, beginning
  of period                                       691,770         295,049          26,501               -

Charge to deficit (note 1)                              -         270,590               -         270,590
                                             ------------    ------------   -------------  --------------
Deficit accumulated during the
  development stage, end of period           $  1,430,962    $    691,770   $     295,049  $    1,430,962
                                             ============    ============   =============  ==============
Basic and diluted loss per share             $       0.03    $       0.01   $        0.01  $         0.05
Weighted average number of
  shares outstanding                           27,557,997      24,847,620      20,000,000      21,960,502
                                             ============    ============   =============  ==============

</TABLE>


See accompanying notes to consolidated financial statements.


<PAGE>F-4


HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)
(a development stage enterprise)

Consolidated Statements of Cash Flows
(expressed in U.S. dollars)

<TABLE>
<CAPTION>


                                                                                                                  For the period
                                                                            Three month                             November 24,
                                                         Year ended         period ended         Year ended            1994 to
                                                        December 31,        December 31,        September 30,       December 31,
                                                            1999                1998                1998                1999
                                                       -------------        ------------        -------------       ------------
<S>                                                  <C>                   <C>                 <C>                 <C>
Cash flows from (used in) operating activities:
    Net loss                                           $    (739,192)       $   (126,131)       $    (268,548)      $ (1,160,372)
    Items not involving the use of cash:
        Depreciation                                             472                 114                  280                866
        Employee equity compensation                         222,500                   -                    -            222,500
        Shares issued as a financing fee                           -               5,000                    -              5,000
    Changes in non-cash operating working capital:
        Accounts receivable                                   31,120             (37,549)               2,403             (2,543)
        Accounts payable and accrued
         liabilities                                         (10,096)             20,550               10,730             21,259
        Deposit on building                                        -                   -               10,158                  -
                                                       -------------        ------------        -------------       ------------
                                                            (495,196)           (138,016)            (244,977)          (913,290)
Cash flows used in investing activities:
    Capital expenditures                                           -                   -               (1,868)            (1,868)

Cash flows from financing activities:
    Issuance of common shares                                      -                   -                    -                657
    Loans from related parties:
        Kafus Industries Ltd.                                420,828             132,149               19,900            572,877
        Cameron Strategic Planning Ltd.                       66,827              14,470              174,060            305,217
        Mr. Robert L. Novitsky                                     -                   -               39,744             39,744
        Kafus Bio-Composites Inc.                              1,107                   -                    -              1,107
                                                       -------------        ------------        -------------       ------------
                                                             488,762             146,619              233,704            919,602
Effect of exchange rate changes on
  foreign currency cash balances                                 442                (127)                 (74)            (1,226)
                                                       -------------        ------------        -------------       ------------
Increase (decrease) in cash                                   (5,992)              8,476              (13,215)             3,218
Cash, beginning of period                                      9,210                 734               13,949                  -
                                                       -------------        ------------        -------------       ------------
Cash, end of period                                    $       3,218        $      9,210        $         734       $      3,218
                                                       =============        ============        =============       ============
Supplementary information:
  Interest paid                                        $           -        $          -        $           -       $          -
  Income taxes paid                                                -                   -                    -                  -
  Non-cash transactions:
      Issuance of common shares:
        For investment in Camden Agro-Systems Inc.                 -             270,590                    -            270,590
        As a financing fee                                         -               5,000                    -              5,000
        Options issued as employee
         equity compensation                                 222,500                   -                    -                  -
                                                       =============        ============        =============       ============
</TABLE>

See accompanying notes to consolidated financial statements.


<PAGE>F-5

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)


1.   Nature and continuance of operations:

     Hyaton Organics Inc. (formerly Hyaton Company Incorporated)  ("Hyaton") was
     incorporated  pursuant  to the laws of the State of  Nevada  on August  20,
     1996.  Effective  November 2, 1998, Hyaton holds a 90% investment in Camden
     Agro-Systems Inc. ("CASI"), a Canadian company, as its sole asset. Prior to
     that date Hyaton was inactive.

     CASI was incorporated under the Ontario Business Corporations Act (1982) on
     November 24, 1994 to carry on the  business of  management  consulting  and
     product   development.   CASI's  efforts  have  focused  primarily  on  the
     development of organic  fertilizers  and animal feed from animal waste.  In
     early  1999,  CASI's  management   discontinued  its  efforts  towards  the
     development of organic animal feed.

     Pursuant to the Plan and  Agreement  of  Reorganization  dated  November 2,
     1998, Hyaton issued 20,000,000 common shares from treasury for 9,000 issued
     and outstanding  common shares of CASI  representing a 90% holding in CASI.
     In addition,  the agreement  provides for the issuance of additional shares
     of Hyaton to the vendor of the 9,000 common shares of CASI at a rate of one
     common share for every $0.20 of earnings before interest, tax, amortization
     and  depreciation  of CASI for the  period  from  November  2,  1998 to the
     earlier  of  November  2,  2000  or 18  months  from  the  commencement  of
     commercial operations.  Furthermore,  the agreement provides for additional
     share  issuances at a rate of one share for every $0.05 of losses  incurred
     by the vendor under the  indemnification  granted to the vendor against any
     legal claims and other  contingencies.  Related to the  agreement,  500,000
     common shares of Hyaton were issued to Securities Trading Services Inc., an
     unrelated party, as a financing fee.

     The  agreement  resulted  in  control  of  Hyaton  passing  to  the  former
     shareholders   of   CASI.   The   transaction   is   accounted   for  as  a
     recapitalization  of CASI,  as if CASI had issued  common shares to acquire
     the net monetary  assets of Hyaton.  The financial  statements  reflect the
     operations  of CASI  from its  inception  with  the  activities  of  Hyaton
     consolidated from November 2, 1998, the date of the transaction.

     At the date of the  reorganization,  the net assets of Hyaton were nominal.
     The par value of Hyaton  shares  issued of  $275,590  has been  included in
     capital  stock  with an offset of  $270,590  to the  deficit  and $5,000 to
     consulting  fee expense.  The excess of $13,879 of the costs  incurred over
     the cash on hand in Hyaton at the date of  acquisition  has been charged to
     expense.  The contingent shares issuable by Hyaton will be accounted for as
     an additional cost of purchase, if and when issued.


    Consideration:
      Par value of common shares issued                   $  275,590
      Costs                                                   13,879
                                                          ----------
                                                          $  289,469
                                                          ==========
<PAGE>F-6

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)


1.  Nature and continuance of operations (continued):


    Consideration applied to:
        Net assets                                            $       -
        Less:
           Consulting expense                                     5,000
           Cash costs incurred in excess of cash on hand         13,879
           Charge to deficit                                    270,590
                                                              ---------
                                                              $ 289,469
                                                              =========

     (a)  Future operations:

          These  consolidated  financial  statements  have been  prepared on the
          basis of a going concern, which contemplates the realization of assets
          and the  satisfaction of liabilities in the normal course of business.
          The  Company  has  suffered  recurring  losses  and has not  generated
          profitable operations since inception.  The continuance of the Company
          as a going  concern is dependent on obtaining  financing for continued
          operations and the  construction of a  manufacturing  facility for its
          fertilizers,  the  attainment  of  profitable  operations,  which  are
          consistent with management's  plans and intentions,  and the avoidance
          of any cash costs from early redemption of loans from related parties.
          If the  Company  is  unable to  achieve  these  objectives,  it may be
          obligated to liquidate certain assets in settlement of liabilities and
          the value achieved on settlement may be less than the assets' carrying
          values.

     (b)  Development stage enterprise:

          For  U.S.  accounting  purposes  the  Company  is  considered  to be a
          development  stage  enterprise  from the inception of CASI on November
          24, 1994 to December  31, 1999 as its efforts are  primarily  directed
          towards the  development of a new product.  The  identification  of an
          entity  as  a  development   stage  enterprise  does  not  impact  the
          measurement and recognition  principles  applied in these consolidated
          financial  statements  but does  require the  disclosure  of specified
          cumulation from inception and other information.


2.   Significant accounting policies:

     The consolidated financial statements have been prepared in accordance with
     generally accepted accounting principles in the United States.

     (a)  Principles of presentation:

          These consolidated financial statements include the accounts of Hyaton
          and its 90% owned  subsidiary,  CASI.  All  intercompany  balances and
          transactions have been eliminated.

          The  preparation of financial  statements in accordance with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of assets  and
          liabilities and the disclosure of contingent assets and liabilities at
          the date of the  financial  statements  and the  reported  amounts  of
          revenues and expenses  during the  reporting  period.  Actual  results
          could differ from these estimates.

<PAGE>F-7

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)



2.   Significant accounting policies (continued):

     (b)  Foreign currency translation:

          These consolidated financial statements are presented in U.S. dollars.
          Hyaton's  functional  currency  is the  U.S.  dollar.  The  functional
          currency  of  CASI  is the  Canadian  dollar  as the  majority  of its
          operations occur in Canada and are conducted in Canadian dollars.  The
          Canadian dollar accounts have been translated into U.S.  dollars using
          the  exchange  rate in effect at the balance  sheet date for asset and
          liability  amounts and at the average exchange rate for the period for
          amounts included in the  determination of income.  Any gains or losses
          from  this  translation  are  included  in  the  separate   cumulative
          translation   adjustment  account  in  shareholders'   equity  in  the
          consolidated balance sheet.

          Transactions  denominated  in other  than the  operation's  functional
          currency are  measured at exchange  rates in effect at the date of the
          transactions   with  exchange   gains  and  losses   included  in  the
          determination of income.

     (c)  Computer equipment:

          Computer equipment is recorded at cost.  Depreciation is calculated on
          the declining-balance  basis from the date of acquisition at a rate of
          30% per annum.

     (d)  Income taxes:

          The Company  follows the asset and liability  method of accounting for
          income taxes.  Under this method,  deferred tax assets and liabilities
          are  recognized   based  on  the  estimated  future  tax  consequences
          attributable to differences  between the financial  statement carrying
          amounts of existing assets and  liabilities  and their  respective tax
          bases and of loss carry forwards.  Deferred tax assets and liabilities
          are measured  using  enacted tax rates in effect for the year in which
          those  temporary  differences are expected to be recovered or settled.
          The effect on deferred tax assets and  liabilities  of a change in tax
          rates  is  recognized  in  income  in the  period  that  includes  the
          enactment date. To the extent that the realizability of the benefit of
          deferred  tax assets is not  considered  to be more likely than not, a
          valuation allowance is provided.

     (e)  Revenue recognition:

          Revenue  relating  to  consulting  services  is  recognized  when  the
          professional services have been rendered.

     (f)  Research and development costs:

          Research and developments costs are expensed as incurred.

     (g)  Stock option plan:

          The Company has a stock-based  compensation plan which is described in
          note 4(b).  For  accounting  purposes these options are deemed to have
          been  granted  in the year  ended  December  31,  1999.  For grants to
          employees,  compensation expense is recognized over the vesting period
          in an amount equal to the difference, if any, between the market value
          of the  Company's  common  shares  at that  measurement  date  and the
          exercise price.  The value recognized for option grants is included in
          the   consolidated   statements  of  operations  as  "employee  equity
          compensation".  Options granted to  non-employees  will be recorded at
          their fair value.


<PAGE>F-8

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)


2.  Significant accounting policies (continued):

     (h)  Loss per share:

          Loss per share is  calculated  using the  weighted  average  number of
          shares outstanding during the fiscal period.  This average includes as
          outstanding  common shares,  shares issued in a reporting  period from
          the date of their  issuance.  Fully  diluted per share amounts are not
          presented  as the  effect  of  outstanding  stock  options  and  other
          convertible securities is anti-dilutive.


3.   Related party transactions and balances:

     Kafus Industries Ltd., a public company,  is a majority  shareholder of the
     Company.  Cameron Strategic Planning Ltd., a private Canadian company,  and
     Kafus  Bio-Components Inc., a U.S.  corporation,  are subsidiaries of Kafus
     Industries Ltd.

     Mr. Robert L.  Novitsky is an officer of the Company and a shareholder  and
     officer of CASI.

     The  Company  has  entered  into  the  following   material  related  party
     transactions:

     (a)  Loans from related parties:

          Loans from related parties consist of the following:

                                                     1999             1998
                                                     ----             ----
        Kafus Industries Ltd.                     $  591,301        $ 149,457
        Cameron Strategic Planning Ltd.              308,302          224,148
        Mr. Robert L. Novitsky                        40,140           39,206
        Kafus Bio-Composites Inc.                      1,107               -
                                                  ----------        ---------
                                                  $  940,850        $ 412,811
                                                  ==========        =========

          The loans  from  related  parties  are  non-interest  bearing  with no
          specific  terms of repayment.  The loan from Mr. Robert L. Novitsky is
          convertible  into common shares of the Company,  prior to financing of
          the first manufacturing plant, on a mutually acceptable basis.

     (b)  Accounts payable and accrued liabilities:

          Included in accounts  payable and accrued  liabilities is $nil (1998 -
          $5,052) payable to a private  company  controlled by an officer of the
          Company.

     (c)  Fees:

          The Company has been charged administrative, management and consulting
          fees  aggregating  $155,725  (three  months ended  December 31, 1998 -
          $34,777; year ended September 30, 1998 - $70,365) by certain officers,
          directors and private companies controlled by them.

<PAGE>F-9

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)



4.   Capital stock:

     (a)  Issued:

<TABLE>
<CAPTION>


                                                                    Number        Value          Assigned
                                                                  of shares     per share          value
                                                                 ----------     ---------       -----------

<S>                                                            <C>             <C>           <C>
     Issued for cash at inception, November 24, 1994                  1,000       $0.657        $       657
                                                                 ----------     ---------       -----------
        Issued and outstanding at all period ends prior to
         September 30, 1998                                           1,000                             657

        Issued during period ended December 31, 1998:
        For investment in CASI                                   27,058,000         0.01            270,590
        For financing fee                                           500,000         0.01              5,000
                                                                 ----------     ---------       -----------
        Issued and outstanding at December 31, 1998              27,559,000                         276,247

        Adjustments resulting in an increase in
          additional paid-in capital:
           Shares cancelled                                          (3,000)        0.01                (30)
           Authorized par value change                                    -                            (657)
                                                                 ----------     ---------       -----------
        Issued and outstanding at December 31, 1999              27,556,000                     $   275,560
                                                                 ==========     =========       ===========

</TABLE>



          Shares  issued for non-cash  consideration  have been  recorded at the
          market value of the shares on the date at which the obligation arises.

     (b)  Options:

          (i)  During  1999,  the  directors  of the Company  approved the "1999
               Stock  Option  Plan"  (the  "Plan").   The  Plan  is  subject  to
               shareholder  approval  which is intended to be  requested  at the
               next annual general meeting. Generally, the Plan provides for the
               granting  of  options  to  employees,   officers,  directors  and
               consultants  to the Company.  On October 15, 1999,  the Company's
               directors  approved the grant of 445,000 stock options  having an
               exercise  price of $1.50 each and an expiry  date of October  13,
               2004 to  employees,  officers  and  directors.  The  Plan and the
               granting  of these  options  are  intended  to be approved by the
               shareholders  of the  Company  at its annual  general  meeting in
               2000.  The  vesting  date  and  terms  will  also be  subject  to
               shareholders' approval.

<PAGE>F-10

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)


4.  Capital stock (continued):

     (b)  Options (continued):

               In accordance with the Company's  accounting policy for its Plan,
               compensation  expense of  $222,500  has been  recognized  for its
               stock  options equal to the  difference  between the market price
               and exercise  price on the date of board  approval with an offset
               to additional paid-in capital.  As accounting  principles require
               the  disclosure  of  information  as if  the  Company  determined
               compensation  expense  based on the fair  value at the grant date
               for its stock  options,  the  Company's  loss for 1999 would have
               been increased to the pro forma amounts indicated below:


               Net loss:
                 As reported                        $    739,192
                 Per share                             1,304,342

               Basic and diluted loss per share:
                 As reported                        $       0.03
                 Pro forma                                  0.05

               The per  share  weighted-average  fair  value  of  stock  options
               granted  during  1999 was  $1.77  on the  date of  grant  using a
               binomial  option-pricing  model with the  following  assumptions:
               expected dividend yield of 0%, risk-free  interest rate of 6%, an
               expected  life  of  5  years,  and  a  volatility  62.5%.   These
               calculations assume that all options vested at date of grant.

          (ii) Call/put options:

               The Company has entered into a call/put option agreement with the
               minority  shareholder (the  "Shareholder") of CASI exercisable at
               any time on or before November 3, 2003.  Under this option,  both
               Hyaton  and the  Shareholder  have the  option  to  exchange  the
               Shareholder's  1,000 common shares of CASI for 120,000  shares of
               Hyaton common stock at $1.00 per Hyaton share.


5.   Comprehensive income:

     The Company is required to disclose changes in other comprehensive  income,
     which  include  gains and losses that affect  shareholders'  equity but are
     excluded from net income.  The  components of  comprehensive  income to the
     Company  are net  loss  and  changes  in the  foreign  currency  cumulative
     translation adjustment account.

<TABLE>
<CAPTION>

                                                                                                        For the period
                                                                      Three month                         November 24,
                                                   Year ended         period ended     Year ended           1994 to
                                                  December 31,        December 31,    September 30,      December 31,
                                                      1999               1998              1998              1999
                                                  ------------        ------------    ------------       -------------
<S>                                             <C>                 <C>              <C>                 <C>
    Comprehensive income (loss):
        Net loss                                  $   (739,192)       $   (126,131)   $   (268,548)      $    (927,472)
        Currency translation adjustment                (38,875)              4,261          15,216             (22,660)
                                                  ------------        ------------    ------------       -------------
                                                  $   (778,067)       $   (121,870)   $   (253,332)      $    (950,132)
                                                  ------------        ------------    ------------       -------------
</TABLE>


<PAGE>F-11

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)



6.   Contingencies:

     (a)  Legal claims:

          In the  normal  course of  business,  the  Company  may be  subject to
          various claims and contingencies related to lawsuits,  taxes and other
          matters.  Management believes the ultimate liability,  if any, arising
          from such  claims or  contingencies  is not  likely to have a material
          adverse  effect on the  Company's  results of  operations or financial
          condition.

     (b)  Concentration of risk:

          The Company was formed to develop,  operate,  finance, and construct a
          manufacturing  facility  which will produce  high  quality  fertilizer
          products  from  animal  waste.  Because  a project  of this  scope and
          technology has not yet been completed,  there is concentration of risk
          inherent in the  Company's  business,  including,  but not limited to,
          technology, construction, financing, and operations risk.


7.   Income taxes:

     The  Company  has  approximately  $845,000 of  non-capital  losses  carried
     forward available to reduce taxable income otherwise  calculated in Canada.
     These losses expire up to 2006.

                                                      1999             1998

    Future tax asset:
        Non-capital loss carry forwards           $   845,000       $  360,000
        Less valuation allowance                     (845,000)        (360,000)
                                                  -----------       ----------
    Net future tax assets                         $         -       $        -
                                                  ===========       ==========
    Future tax liabilities                        $         -       $        -
                                                  ===========       ==========


8.   Financial instruments:

     (a)  Fair value:

          The fair values of financial  instruments  included in current  assets
          and liabilities  (excluding  loans from related  parties) are equal to
          their carrying  values due to their ability for prompt  liquidation or
          the short-term to their settlement.

          The fair  value of loans from  related  parties  cannot be  reasonably
          estimated due to the nature of the amounts due and their  relationship
          between  the  liable  party  and the  Company  and the lack of a ready
          independent market for such amounts payable.

     (b)  Currency fluctuation risk:

          The  Company  has not  entered  into  any  material  foreign  exchange
          contracts  to  minimize or  mitigate  the effects of foreign  exchange
          fluctuations   on  the  Company's   operations   or  these   financial
          statements.  However,  as the majority of assets and  liabilities  are
          located in Canada and  originally  denominated  in  Canadian  dollars,
          management does not believe it faces any significant  foreign currency
          fluctuation risk.

<PAGE>F-12

HYATON ORGANICS INC.
(formerly Hyaton Company Incorporated)

(a development stage enterprise)

Notes to Consolidated Financial Statements
(expressed in U.S. dollars)



9.   Segmented information:

     At December 31, 1999, the Company's  operations were primarily  situated in
     Canada or related to operations that are situated in Canada.  Through CASI,
     the Company's primary focus is on the  manufacturing of organic  fertilizer
     from animal waste.  Accordingly,  the Company is considered to operate in a
     single reportable and geographic segment.



                               Purchase Agreement

This Purchase Agreement (this "Agreement"), dated as of the 15th day of February
2000, among:

(1)  Furst-McNess  Company, an Illinois corporation  operating under the laws of
     the United States ("Purchaser"), and

(2)  Hyaton  Organics  Inc., a subsidiary  of Kafus  Industries  Ltd., a British
     Columbia  corporation,  operating  under  the  laws  of the  United  States
     ("Supplier").


                              W I T N E S S E T H:

WHEREAS,  Supplier is developing the Facility to produce Organic  Products (such
terms and all other capitalized terms used herein having the respective meanings
set forth in Section 1).

WHEREAS,  Supplier  desires to obtain a contract  for the purchase of the annual
production of the Facility.

WHEREAS, Purchaser desires to purchase and distribute the Organic Products.

NOW  THEREFORE,  in  consideration  of the premises and the mutual  promises and
agreements herein expressed, and for other good and valuable consideration,  the
receipt  and  adequacy  of which is hereby  acknowledged,  the  parties  hereto,
intending legally to be bound, hereby agree as follows:

SECTION 1.  Definitions

     Unless  otherwise  specified  herein,  the  following  terms shall have the
     meanings  specified below.  The singular shall include the plural,  and the
     masculine shall include the feminine and neuter,  as the context  requires.
     "Includes" or "is including" shall mean  "including",  but not limited to."
     All  definitions  of  agreements  shall include all  amendments  thereto in
     effect from time to time.

     "Agreement" means this Purchase Agreement.

     "Contract  Price"  means  the  price  per Unit of  product  sold  hereunder
     determined in accordance with Section 4.2.

     "Cure Provision Period" has the meaning set forth in Section 6.3.

     "Dollars" and "$" means lawful currency of the United States.

     "Facility" means the plant to be developed, financed, constructed and owned
     by the Supplier at a site in Merry Hill, North Carolina.

     "Final  Completion  Date" means the date when the  following  condition  is
     satisfied:  Supplier's  construction contractor certifies that the Facility
     has completed performance testing and has performed to the degree necessary

<PAGE>

     to  constitute   substantial  completion  (or  its  equivalent)  under  the
     construction  contract and is capable of  producing  annually not less than
     the volumes prescribed in Schedule A.

     "Financial   Closing"  means  the  execution  and  delivery  of  definitive
     documentation  for the financing of all costs of construction,  procurement
     and equipping of the Facility which will not be financed by Supplier or its
     affiliates.

     "Force Majeure" has the meaning set forth in Section 9.

     "Initial Delivery Date" has the meaning specified in Section 2.4.

     "Initial,  Basic and Operating Terms" mean the periods described in Section
     2.1.

     "Mechanical  Completion  Date" means the date which Supplier and Supplier's
     construction  contractor  agree is the  date  that  the  Facility  has been
     completed  to the  extent  necessary  to  begin  start-up  and  performance
     testing.

     "Minimum Purchase Price" has the meaning specified in Section 4.1(b).

     "Product" means Organic  Products meeting the  Specifications  set forth in
     Section 8.0 and produced using  technology of Hyaton  Organics Inc.,  which
     technology is, as of the date of this Agreement, proprietary.

     "Purchase Order" has the meaning specified in Section 3.3(a).

     "Required  Annual Amount" means the amount of product in tons as set out in
     section 3.1 (b), or if less,  the maximum  that the Facility can product in
     any given Contract Year.

     "Selling Price" has the meaning set forth in Section 4.1.

     "Shipment"  means  product  identified  on a single  invoice and shipped to
     Purchaser pursuant to this Agreement.

     "Specifications"  means, with respect to Product,  the  specifications  set
     forth in Section 8.0

     "Term" means, collectively, the Initial Term, and the Operating Term.

SECTION 2.  Term; Development of Facility

2.1  Basic Term

(a)  This Agreement  shall be effective from the date hereof and, unless earlier
     terminated in accordance with this Agreement,  continue until the fifth (5)
     anniversary of the Final  Completion  Date. The period from the date hereof
     until the Final  Completion Date is herein called the "Initial  Term".  The
     period from the date following the Final  Completion  Date to the fifth (5)
     anniversary  of the Final  Completion  Date is herein called the "Operating
     Term".

(b)  At least six (6) months prior the  expiration  of the Operating  Term,  the
     parties may agree to renew this  Agreement for an additional  five (5) year
     term,  starting Final Completion Date on the terms of the initial Agreement
     or under new terms agreed by both parties.

<PAGE>

(c)  Notwithstanding  Paragraph  (b) above,  if the parties  have not reached an
     agreement,  Supplier  will be  entitled  to seek  arrangements  with  other
     parties for the  marketing of Products.  Supplier  will not contract with a
     third  party on better  terms  without  first  offering in writing the same
     terms and conditions to Purchaser.  Purchaser  shall have fifteen (15) days
     from receipt of such notice to accept or reject the third party  offer.  If
     Purchaser declines, Supplier upon six (6) months notice may contract with a
     third party.

(d)  Notwithstanding  Paragraph (c) above,  Supplier shall fulfill forward sales
     orders placed by Purchaser as under the original terms of the Agreement.

2.2  Construction Progress

     Supplier  agrees to keep  Purchaser  informed  periodically  of progress in
     construction  of the Facility and to notify  Purchaser  immediately  of any
     changes in the construction schedule that materially affect the anticipated
     Initial Delivery Date.

2.3  Financial Closing

     Should  Financial  Closing not have occurred  within two (2) years from the
     execution of this  Agreement,  Purchaser  may terminate  this  Agreement by
     written  notice of intent to  terminate  given not less than six (6) months
     prior to the effective date of termination; provided, however, that:

(a)  Supplier shall have the right to extend the deadline for Financial  Closing
     on one or more successive  occasions for up to three  additional  months in
     the  aggregate,  by notice to  Purchaser  given on or prior to the  initial
     deadline for Financial  Closing or any subsequent  deadline then in effect,
     which  notice  shall state that  Supplier is  diligently  and in good faith
     working to consummate  Financial Closing and such extension is necessary to
     enable Financial Closing to occur based upon a term sheet for all necessary
     Facility  financing  having  been  executed  by  Supplier  and the party or
     parties providing financing, and;

(b)  Termination shall not be effective if Financial Closing occurs on or before
     the date  Termination  otherwise  would  become  effective  pursuant to the
     notice given by  Purchaser.  Any  extension  of the deadline for  Financial
     Closing shall cause a corresponding extension of the deadline for the Final
     Completion Date set forth in Section 2.5.

(c)  In the event that  Purchaser  terminates  the Agreement as outlined  within
     this  Section  2.3,  then  Supplier  shall  reimburse   Purchaser  for  all
     reasonable  marketing  expenses  agreed  to  by  the  parties  incurred  by
     Purchaser in anticipation of supply of Product from the Supplier.

2.4  Initial Delivery Date

(a)  After the  Mechanical  Completion  Date but  prior to the Final  Completion
     Date,  when the  Facility  is  capable of  producing  Product  meeting  the
     Specifications,  Supplier shall notify  Purchaser and designate the date of
     anticipated  shipment of the first  quantities of Product to Purchaser (the
     "Initial Delivery Date").

(b)  Should the Mechanical  Completion  Date not have occurred within the period
     of 12 months  after the date of  Financial  Closing  (as such period may be
     extended in  accordance  with Section 2.3),  Purchaser  may terminate  this
     Agreement by notice to Supplier of intent to terminate  given not less than

<PAGE>

     30 days prior to the  effective  date of  termination;  provided,  however,
     that:

     i.   Supplier  shall have the right to extend the deadline  for  Mechanical
          Completion  Date on one or  more  successive  occasions  for up to six
          additional months in the aggregate, by notice to Purchaser given on or
          prior to the initial  deadline for Mechanical  Completion  Date or any
          subsequent  deadline  then in effect,  which  notice  shall state that
          Supplier,  and Supplier's  contractor are diligently and in good faith
          working to complete the construction of the Facility to the point when
          the Mechanical Completion Date will be deemed to have occurred; and,

     ii.  Termination  shall not be effective if the Mechanical  Completion Date
          occurs  on or  before  the date  termination  otherwise  would  become
          effective pursuant to the notice given by Purchaser.

2.5  Final Completion Date

     Should the Final  Completion Date not have occurred within the period of 18
     months after the date of Financial  Closing (as such period may be extended
     in accordance with Section 2.3),  Purchaser may terminate this Agreement by
     notice to Supplier of intent to terminate given not less than 30 days prior
     to the effective date of termination; provided, however, that:

     (a)  Supplier  shall  have the  right to  extend  the  deadline  for  Final
          Completion  Date on one or  more  successive  occasions  for up to six
          additional months in the aggregate, by notice to Purchaser given on or
          prior to the initial deadline for Final Completion Date or any

     (b)  subsequent  deadline  then in effect,  which  notice  shall state that
          Supplier,  and Supplier's  contractor are diligently and in good faith
          working to  complete  the  construction  of the  Facility to the point
          Final  Completion  Date will be deemed to have  occurred  and that the
          Facility is substantially complete; and,

     (c)  Termination shall not be effective if the Final Completion Date occurs
          on or before the date  Termination  otherwise  would become  effective
          pursuant to the notice given by Purchaser.

SECTION 3. Sale and Purchase

3.1  Sale and Purchase

     (a)  Subject to the terms and  conditions  herein set forth,  commencing on
          the Initial Delivery Date,  Supplier agrees to sell to Purchaser,  and
          Purchaser  agrees to market and purchase  from  Supplier,  all Product
          manufactured at the Facility during the Operating Term and all Product
          manufactured  at the  Facility  during  any  Contract  Year  up to the
          Required Annual Amount for each Contract Year.

     (b)  The Required Annual Amount for the duration of this contract estimated
          by Supplier are as follows: (Schedule A)

                             Year 1         15,000 (short tons-2000 lbs.)
                             Year 2         30,000 short tons
                             Year 3-5       50,000 short tons

<PAGE>

3.2  Distributorship

     Purchaser  shall use all  reasonable  efforts and due diligence to promote,
     market  and  distribute  Product  and  at its  own  expense  shall  provide
     aggressive,  dedicated,  continuous sales representation by means of actual
     sales personnel contact with existing and prospective customers of Product.
     Supplier and Purchaser shall establish a co-operative program pertaining to
     the  establishment  of  the  Products'   trademarks  and  subsequent  media
     promotion  thereof.  Costs  pertaining  directly to product  and  trademark
     development  as well as  direct  brand  media  spending  will be  borne  by
     Supplier. Supplier and Purchaser shall communicate as required and at least
     semi-annually  the parties shall have a joint marketing  meeting to be held
     at  a  convenient  location  for  the  parties.  In  connection  therewith,
     Purchaser shall, among other things at its own expense;

     (i)  respond to all inquiries concerning Product,

     (ii) maintain  sufficient  equipment,  and hire and  maintain a sales staff
          sufficient  in number  and  qualifications  to  aggressively  promote,
          distribute and sell Product, and

     (iii)develop in  conjunction  with Supplier from time to time and implement
          such advertising  strategies for Product as necessary and agreed to by
          the  parties.  Within  15  business  days  following  the  end of each
          calendar month,  Purchaser shall deliver to Supplier a sales report in
          a form satisfactory to both parties.

3.3  Purchase Orders

     (a)  In order to  accommodate  the  continuous  production  process  of the
          Facility,  Purchaser  shall confer with Supplier to establish  monthly
          Product  Purchase Order  requirements at intervals of six months,  two
          months and one month.  Purchaser shall deliver to Supplier  individual
          purchase  orders covering each month's  shipments at least  twenty-one
          (21) days in advance  of the  desired  shipping  date  specifying  the
          Selling  Price,  packaging  requirements  of the  Product  required by
          Purchaser  (each,  a  "Purchase  Order").  To the extent  practicable,
          Supplier will use its best efforts to accommodate  Purchase  Orders on
          shorter  notice as may be required from time to time,  but in no event
          shall  Purchaser  request  changes to such Purchase Order less than 48
          hours prior to expected delivery from the Facility.

     (b)  All Product  purchased by  Purchaser  shall be shipped in such lots as
          the parties may agree.

     (c)  All  monthly  Product  requirements  as  previously  agreed  to by the
          Purchaser will be transported  from the Facility  during the month. In
          the event that contracted Product is not removed from the Facility,  a
          storage charge will be levied to the Purchaser.

     (d)  Supplier  shall  invoice each  shipment at the time of delivery to the
          carrier.  Invoices shall include the Purchase Order Number,  quantity,
          types of product, selling price and any applicable taxes.

3.4  Additional Features

     The parties  agree to discuss on an ongoing basis  different  varieties and
     packaging forms for the Product and other additions or deletions that would
     provide  additional  revenue  benefits to the Supplier and  Purchaser.

<PAGE>

3.5  Delivery

     All Product  Purchase  Orders are F.O.B.  Facility by the  Purchaser's  own
     carrier or contracted carrier at the Purchaser's expense.

SECTION 4. Pricing

4.1  (a) Selling Price

     With respect to any Product  purchased by Purchaser and sold by Supplier to
     Purchaser  hereunder,  the "Selling Price" for each Purchase Order shall be
     the price at which the  Purchaser,  exercising its best efforts to maximize
     price,  has resold the Product to the end user, which is the subject of the
     Purchase  Order.  In the event Product  purchased by Purchaser has not been
     pre-sold by Purchaser,  the minimum purchase price (4.1(b)) will be applied
     to the  subject  Product.  If the  actual  selling  price  received  by the
     Purchaser from the end user is higher than the minimum  purchase price, the
     entire amount shall be recalculated  and adjusted in favour of the Supplier
     and will be credited in the next month's reconciliation statement.

4.1  (b) Minimum Purchase Price

     A guaranteed  minimum  purchase price F.O.B.  Facility is to be established
     annually  on  each  anniversary  date  of the  Agreement  to the  Purchaser
     (Schedule B).

4.2  Basis of Payment

     Purchaser  will  provide a  statement  on a  monthly  basis  showing  total
     volumes, revenues and costs (defined under Net Selling Price below) for all
     Products  sold or  stored  within  ten (10)  days of the  previous  monthly
     period.  The statement  will be  accompanied  by payment from  Purchaser to
     Supplier for the amount due for all Product  purchased  and  received  from
     Supplier during the preceding  monthly period.  Any Product shipped that is
     not  pre-sold as set out in (4.1),  will be invoiced  to  Purchaser  at the
     Minimum  Purchase  Price (4.1 (b)) at month end and will be due for payment
     within 15 days.

     Percentage  revenues  (commission)  to Purchaser shall be calculated on the
     Net Selling Price (as per the schedule below) and payment will be forwarded
     to Purchaser from Supplier within f15 days of receipt of statement and full
     payment from Purchaser.

     Commission  Revenue payment to Purchaser from the Supplier for the Products
     purchased during the previous month will be based on the following table:

                             Net Selling Price       % to Purchaser

        (a) Fertilizers             (1)                     (1)
                                    (1)                     (1)
                                    (1)                     (1)

        (b) Growing Media           (1)                     (1)
                                    (1)                     (1)
                                    (1)                     (1)
        * short ton (2000 pounds)

(1)  Confidential  portion  has  been  omitted  and  filed  separately  with the
     Commission.

<PAGE>


     NET  SELLING  PRICE  shall be defined  as the sale price of the  Product to
     Purchaser's  customers (end user) after deducting all direct costs relating
     to the  customers'  orders for freight,  storage,  interest  carrying cost,
     handling  and custom  cost  actually  incurred by  Purchaser  but shall not
     include Purchaser's overhead or fixed cost (Schedule C).

     Purchaser  shall be entitled to set selling  prices but shall keep Supplier
     informed of its pricing structure.

4.3  Product Only

     All prices  under this  Agreement  are for Product  only and do not include
     technical data,  proprietary  rights of any kind, or patent rights, and any
     packaging other than normal domestic commercial packaging, unless expressly
     agreed to in writing by the Supplier.

SECTION 5. Title and Risk of Loss

     Title  and  risk of loss  for all  product  sold  hereunder  shall  pass to
     Purchaser  upon  delivery  onto  Purchaser's  or  Purchaser's   contractors
     equipment at the  Facility  and the sale by Supplier to  Purchaser  will be
     complete  upon such  delivery,  Purchaser  being  deemed  to have  accepted
     delivery thereof.

SECTION 6. Default.

6.1  Default

     Notwithstanding anything herein contained,  either party may terminate this
     Agreement upon written notice to the other party in the event that;

     (a)  such other party  commits a breach  (other than a breach  which in all
          the circumstances is insignificant) of any provision of this Agreement
          (which notice must specify in reasonable detail the breach or breaches
          complained of);

     (b)  Supplier decides to close the Facility producing the Product;

     (c)  Such other party becomes the subject of any bankruptcy,  insolvency or
          similar proceedings;

     (d)  Any legislation, regulations, policy, ruling or decision of a Federal,
          State  or  Municipal   government   or  of  any  agency   thereof  are
          implemented,  repealed  or altered  in such a way as to  significantly
          prevent either party from lawfully exercising its rights or performing
          its obligations hereunder.

6.2  Remedies

     Upon the occurrence and during the  continuation of any default  hereunder,
     the party not in default shall have the right:

<PAGE>

     (a)  to give written  notice of the party's  intention  to  terminate  this
          Agreement  and  thus  begin  the  Cure  Provision   Period   effective
          immediately upon the other party's receipt of such notice; and

     (b)  to pursue  any other  remedy  given  under  this  Agreement  or now or
          hereafter existing at law or in equity or otherwise.

6.3  Cure Provision Period

     Upon written notice being received by either party of the other's intention
     to terminate,  a Cure Provision  Period of 30 days from the date of receipt
     of such notice shall commence.  During this period, the party receiving the
     notice will have the  opportunity  to correct the situation  giving rise to
     the  termination  notice and to make  current any amounts past due that may
     have arisen from such  situation.  Failure to correct (or in the event such
     correction cannot by its nature be accomplished  within 30 days, failure to
     start and  diligently  proceed to correct)  the  situation  during the Cure
     Provision  Period or the waiving of the Cure Provision  Period by the party
     in receipt of the  termination  notice will result in the  notifying  party
     having the right to terminate the Agreement immediately.  In the event of a
     correction which cannot be accomplished within 30 days, and notwithstanding
     the immediately  preceding  sentence,  either party shall have the right to
     invoke the remedies  specified in Section 6.2 above if a default  continues
     for more than 90 days following the defaulting party's receipt of notice of
     termination.

SECTION 7. Warranty; Indemnification; Insurance.

7.1  Warranty

     Supplier warrants to Purchaser that all Product sold to Purchaser hereunder
     shall be free and clear of liens,  claims,  encumbrances,  and restrictions
     against sale of any type or nature not  authorized by this  Agreement,  and
     shall at the time of delivery to the carrier conform to the  Specifications
     and the descriptions  thereof in the Purchase Order covering the product in
     question.

7.2  Indemnification

     Each of the  parties  hereto  covenants  and agrees to  indemnify  and hold
     harmless the other against and from any and all liability,  damages, losses
     and  costs  (including  without  limitation   reasonable  attorneys'  fees)
     suffered  or incurred by such other party as a result of any breach of this
     Agreement  by the other  party other than any  negligent  act or neglect of
     itself, its servants, employees, agents, invitees, or licensees,  including
     liability for injury or damage to any person or property.

7.3  Liability Insurance

     Supplier and Purchaser shall each provide and keep in force,  comprehensive
     general  liability  insurance  in  respect  of  personal  injury,  death or
     property damage with generally accepted insurance carriers as are customary
     for risks of this  nature and with  minimum  amounts of  $5,000,000.00  per
     occurrence  and  each  party  will  provide  to the  other,  proof  of such
     insurance and renewal thereof, upon request.


<PAGE>

SECTION 8. Product Features

8.1  Product Specifications

     The  Products  sold under the "Truly  Organic"  brand name are pure organic
     fertilizers  and pure organic  growing media  (substrates)  that contain no
     chemical additives and are formulated on a bio-modulated release basis. The
     Products are produced from selected  organic waste materials that have been
     aerobically processed under specific, optimally controlled conditions.

     The Products  will be formally  certified by a recognized  national  and/or
     state  organic  certification  body,  such as OMRI (The  Organic  Materials
     Review  Institute)  and/or any other  regulatory body required by law where
     the Product is sold.

     (i)  Growing Media:

          Professional-All Purpose Mix      -consumer retail market
                                            -ready-to-use
                                            -complete multi-purpose blend
                                            -packaged in multi-color, laminated,
                                             re-sealable bags

     (ii) Fertilizer

          MTO (Magic  Touch   Organic)      -consumer retail market
                                            -pelletized pure organic fertilizer
                                            -general purpose use
                                            -packaged in multi-color, laminated,
                                             re-sealable bags

     (iii)Compost - detailed  specifications  and packaging  shall be determined
          and agreed to by the parties acting  reasonably and attached hereto as
          a schedule prior to production of same.

     (iv) Enhanced Growing Media - detailed  specifications  and packaging shall
          be  determined  and agreed to by the  parties  acting  reasonably  and
          attached hereto as a schedule prior to production of same

     Dependant on market  demands and  conditions,  the Supplier in  conjunction
     with the Purchaser  will develop other products and packaging to meet other
     markets' and customers' needs.

8.2  Product Claims

     Purchaser  agrees to service all claims made or submitted by its  customers
     arising  out of the  sale of  Product  under  this  Agreement  in the  best
     interests of Supplier;  provided, however, that claims in excess of $500.00
     shall not be settled by  Purchaser  without the prior  written  approval of
     Supplier, which approval shall not be unreasonably withheld or delayed. For
     claims under $500.00,  Purchaser  shall settle the claim in accordance with
     this Section 8.2, and an  adjustment  shall be made by Supplier in the next
     regularly prepared billing statement to reflect such settlement and payment
     by Purchaser.  For claims over $500.00,  Purchaser  shall  promptly  notify
     Supplier of such claim and upon  settlement  agreement,  Supplier shall pay
     for such claim directly.

<PAGE>

SECTION 9. Force Majeure

     If any cause reasonably  beyond the control of either party,  including but
     not limited to fire, tempest,  earthquake,  inclement weather,  Act of God,
     power interruption,  fuel shortage, strike, lockout or other labor dispute,
     riot or civil commotion,  act of public enemy or enactment,  rule, order or
     act  of  government  or  governmental  agency,  prevents  such  party  (the
     "defaulting  party") from  complying  with any provision of the  Agreement,
     then the defaulting  party shall be excused from complying while such cause
     continues to prevent the defaulting party from so complying for a period of
     forty-five (45) days.

     Where  non-compliance  by the defaulting party continues beyond  forty-five
     (45) days and relates to a material term or terms of this  Agreement,  then
     the other party shall have the option to terminate this Agreement effective
     upon giving written notice of termination to the defaulting party.

SECTION 10. General Provisions.

10.1 Entire Agreement

     The provisions of this Agreement and the Schedules  attached hereto contain
     the entire  agreement  between  the  parties  concerning  the  transactions
     contemplated  herein and supersede all prior  agreements or  understandings
     between the parties relating to the subject matter hereof,  written or oral
     and all  prior  agreements  or  understandings,  written  or oral,  between
     Purchaser and Supplier or any of their  affiliates  relating to the subject
     matter  hereof.  The  provisions  of this  Agreement  shall  supersede  any
     provisions,  terms and  conditions  contained on any Purchase  Order (other
     than as to the volumes and sizes on a Purchase Order delivered  hereunder),
     sale order or other writing Purchaser or Supplier may give or receive,  and
     the rights of the parties shall be governed  exclusively by the provisions,
     terms and conditions hereof.

10.2 Successors and Assigns

     This  Agreement  shall  inure to the  benefit  of and be  binding  upon the
     parties  hereto and their  respective  successors  and  assigns;  provided,
     however,  that neither  party may assign any of its duties and  obligations
     hereunder  without  the prior  written  consent of the other  party,  which
     consent  shall  not  be  unreasonably  withheld.  In  no  event  shall  any
     assignment  relieve  the  assigning  party of its  obligations  and  duties
     hereunder or impair the rights of the non-assigning party hereunder.

     Notwithstanding the foregoing,  Purchaser hereby agrees and consents to the
     assignment  of this  Agreement  by Supplier for the purpose of financing or
     refinancing  the Facility.  Such  assignment,  for purposes of financing or
     refinancing, may be to any entities providing debt or credit to Supplier or
     the Facility or any trustee or other  representative  of such  entities and
     the initial  assignees  or  designees  thereof  (but not to any  subsequent
     assignees or designees).

     Notwithstanding the foregoing:

     (a)  Purchaser  agrees to execute and  deliver,  at no expense to Supplier,
          such documents  and/or  instruments  as may be reasonably  required by
          Supplier  or any other  person  providing  financing  or  refinancing,
          including,  without  limitation,   opinions  of  counsel  and  written
          confirmation,  as of date of Financial Closing, of the satisfaction by
          Supplier  of  all  conditions  required  to be  satisfied  under  this
          Agreement as of such date.

<PAGE>

     (b)  Supplier  hereby agrees and consents to Purchaser  contracting  with a
          joint venture between Kafus  Industries  Ltd. or an affiliate  thereof
          and  Purchaser  for the joint  venture to supply  market  development,
          research  and  advertising  services in support of the  marketing  and
          distribution of the Product by Purchaser hereunder; provided, that the
          foregoing  shall  not be  deemed to  relieve  Purchaser  of any of its
          duties or obligations thereunder.

10.3 Amendment

     This  Agreement  may not be  modified or  amended,  nor may the  provisions
     hereof be waived, except in writing signed by the parties hereto.

10.4 No Waiver

     Any  waiver by any party  hereto of any of its  rights  hereunder  shall be
     without prejudice to its future assertion of any such right or of any other
     right hereunder, and any delay in exercising any right shall not operate as
     a waiver thereof or any other right.

10.5 Applicable Law

     This  Agreement  shall be governed by and construed in accordance  with the
     laws of the state of North Carolina.

10.6 Headings

     Section headings used herein are for convenience of reference only, are not
     part of this Agreement and are not to affect the  construction of, or to be
     taken into consideration in interpreting, this Agreement.

10.7 Arbitration

     (a)  All disputes, controversies or differences which may arise between the
          parties,  regardless of value should be first attempted to be resolved
          between the parties in a friendly  manner and only once all reasonable
          attempts at resolving such differences have been exhausted,  or where,
          without immediate resolution to an apparently  unresolvable difference
          will cause significant economic hardship on one of the parties,  shall
          Arbitration be used as a method of dispute resolution.

     (b)  All disputes,  controversies,  claims or  differences  which may arise
          between the parties  hereto out of or in relation to or in  connection
          with this  Agreement or the breach thereof where the amount claimed or
          in dispute is  $1,000,000 or less  (exclusive of costs and  attorney's
          fees and expenses) shall be finally  settled by arbitration  conducted
          in accordance with the Commercial  Arbitration  Rules (the "Rules") of
          the ----- American  Arbitration  Association  ("AAA"), as from time to
          time in effect any and all --- disputes  concerning the suitability of
          any Shipment of the Products  purchased  and sold  hereunder  shall be
          determined  by an  independent  testing  laboratory  with  substantial
          industry  experience.  Whenever  any  dispute,  controversy,  claim or
          difference  which may be submitted to  arbitration  under this Section
          10.7 arises between the parties hereto,  either party hereby may given
          to the other party  hereto  notice,  in  accordance  with Section 10.8
          hereof of its intention to submit such dispute, controversy,  claim or
          difference to arbitration.

<PAGE>


     (c)  Arbitration  shall take place before one  arbitrator  agreed to by the
          parties  or,  in the event  agreement  cannot be  reached  about  such
          appointment,  the  arbitrator  shall be  appointed  by the  AAA.  Once
          appointed, such arbitrator shall be neutral.

     (d)  The parties  hereto agree that all fees and expenses  associated  with
          the  arbitration,  including  attorneys'  fees and expenses,  shall be
          borne by the parties as determined by the arbitration.

     (e)  The  determination of such arbitrators shall be final and binding upon
          the parties to the  arbitration,  and judgment upon the award rendered
          by  arbitrators  may be entered in any court having  jurisdiction,  or
          application may be made to such court for a judicial acceptance of the
          award and an order of enforcement, as the case may be. The arbitrators
          shall set forth the grounds for their decisions in the award.

     (f)  The  place of  arbitration  shall be in  Raleigh,  North  Carolina  if
          Arbitration  is initiated by Purchaser and in Raleigh,  North Carolina
          if Arbitration is initiated by Supplier.

10.8 Notices

     All notices and other communications given hereunder must be in writing and
     may be sent by personal delivery,  by overnight courier or delivery service
     for which a  delivery  receipt  can be  obtained,  by  facsimile  for which
     receipt is confirmed or by certified mail, return receipt requested (or the
     functional  equivalent)  to any party at the  address  of the  party  shown
     below.  Any party hereto may change its address by giving notice in writing
     to the other party or parties of such change.

                      if  to Supplier:

                      Hyaton Organics Inc.
                      2285 St.Laurent Blvd.
                      Bldg. C16
                      Ottawa, Ontario
                      Canada
                      K1G 4Z6

                      Attention:    President
                      Telephone:    613-738-0887
                      Facsimile:    613-738-4406


                      if to Purchaser:

                      Furst-McNess Company
                      2100 Oxford St. E.
                      Suite 39
                      London, Ontario
                      Canada
                      N5V 4A4

                      Attention:    Vice President
                      Telephone:    519-659-8600
                      Facsimile:    519-659-1600

<PAGE>


                      Copy:  Furst-McNess Company
                             120 East Clark Street
                             Freeport, Illinois 61032
                             United States

                             Attention;     President
                             Telephone:     815-232-9700
                             Facsimile:     815-232-9765

     All  notices  and  other  communications  given  to  any  party  hereto  in
     accordance  with the  provision of this  Agreement  shall be deemed to have
     been given on the date of receipt if delivered by hand or overnight courier
     service or sent by  facsimile,  or on the date five (5) Business Days after
     dispatch by certified or registered mail if mailed.

10.8 Partial Invalidity

     The  unenforceability  or  invalidity  of any term or  provision  contained
     herein,  or of any  portion  thereof,  shall not  affect  the  validity  or
     enforceability of any other term or provision,  or portion thereof,  herein
     contained.

10.9 No Agency Relationship

     Nothing  contained  in this  Agreement  shall be  construed as creating any
     agency, joint venture or partnership between the parties.  Each party shall
     at all times be an independent contractor under this Agreement.

10.10 Non-Disclosure and Confidentiality

     Supplier  acknowledges  that,  by reason of the  Agreement,  it will become
     privy to  confidential  information  belonging to Purchaser,  including the
     identities of Purchaser's  customers,  agents and  contractors  and pricing
     information.  Supplier  agrees that it will not,  without the prior written
     consent  of  Purchaser,  disclose  to any  third  party  or use for its own
     benefit any such confidential  information either during the continuance of
     the Agreement or thereafter.

     Purchaser   acknowledges   that  it  shall  become  privy  to  confidential
     information such as production forecasts and other information belonging to
     Supplier.  Purchaser  agrees that it will not,  without  the prior  written
     consent of Supplier, disclose to any third party or use for its own benefit
     any such  confidential  information  either during the  continuance  of the
     Agreement or thereafter.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
and delivered by their respective  officers  thereunto duly authorized as of the
date first written above.

                             Hyaton Organics Inc.


                             By:    ____________________________________

                             Name:  Robert Novitsky

                             Title: President

<PAGE>

                             Furst-McNess Company


                             By:    ____________________________________

                             Name:  Jack Smit

                             Title: Vice President, New Business Development


<PAGE>



Schedule A


REQUIRED ANNUAL AMOUNT

Short tons (2000 pounds)



                              TOTAL                         GROWING
                            PRODUCTION       FERTILZER       MEDIA

               YEAR 1        15,000             5,000        10,000
               YEAR 2        30,000            10,000        20,000
               YEAR 3-5      50,000            17,000        33,000


<PAGE>


Schedule B


MINIMUM PURCHASE PRICE - FOB FACILITY

                                                      $US per Short Ton
I.      GROWING MEDIA

           Professional/All-Purpose Mix               $_____ per ton  (1)

II.     FERTILIZERS

           MTO (Magic Touch Organic)                  $_____ per ton (1)


(1)  Confidential  portion  has  been  omitted  and  filed  separately  with the
     Commission.

<PAGE>


Schedule C


NET SELLING PRICE DEFINITION

A.      PRICE TO PURCHASER'S CUSTOMER = ($000)

           LESS

B.      DIRECT COSTS:
          1.      Freight cost to customer from shipping point
          2.      Handling
          3.      Customs
          4.      Storage*
          5.      Interest carrying cost for prepayment of account over 30 days

            EQUALS

C.      NET SELLING PRICE


     *Monthly storage charge including in and out charges at public  warehousing
     facilities.

     Note: Purchaser's overhead and fixed costs not included.


<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-END>                                   DEC-31-1999
<CASH>                                         3,218
<SECURITIES>                                   0
<RECEIVABLES>                                  11,887
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               15,105
<PP&E>                                         1,969
<DEPRECIATION>                                 885
<TOTAL-ASSETS>                                 16,189
<CURRENT-LIABILITIES>                          30,214
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       275,560
<OTHER-SE>                                     (1,230,435)
<TOTAL-LIABILITY-AND-EQUITY>                   16,189
<SALES>                                        0
<TOTAL-REVENUES>                               39,253
<CGS>                                          0
<TOTAL-COSTS>                                  778,445
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (739,192)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (739,192)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (739,192)
<EPS-BASIC>                                  0.03
<EPS-DILUTED>                                  0.03


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission